<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xml:lang="EN" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Neuropsychiatr Dis Treat</journal-id><journal-id journal-id-type="publisher-id">Neuropsychiatric Disease and Treatment</journal-id><journal-title>Neuropsychiatric Disease and Treatment</journal-title><issn pub-type="ppub">1176-6328</issn><issn pub-type="epub">1178-2021</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19337454</article-id><article-id pub-id-type="pmc">2646643</article-id><article-id pub-id-type="publisher-id">ndt-4-1111</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Neurosurgical strategies for Gilles de la Tourette&#x02019;s syndrome</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mukhida</surname><given-names>Karim</given-names></name><xref ref-type="aff" rid="af1-ndt-4-1111">1</xref><xref ref-type="aff" rid="af2-ndt-4-1111">2</xref></contrib><contrib contrib-type="author"><name><surname>Bishop</surname><given-names>Matthew</given-names></name><xref ref-type="aff" rid="af2-ndt-4-1111">2</xref></contrib><contrib contrib-type="author"><name><surname>Hong</surname><given-names>Murray</given-names></name><xref ref-type="aff" rid="af2-ndt-4-1111">2</xref></contrib><contrib contrib-type="author"><name><surname>Mendez</surname><given-names>Ivar</given-names></name><xref ref-type="aff" rid="af2-ndt-4-1111">2</xref><xref ref-type="corresp" rid="c1-ndt-4-1111"/></contrib></contrib-group><aff id="af1-ndt-4-1111"><label>1</label> Division of Neurosurgery, University of Toronto, Toronto, Ontario, Canada</aff><aff id="af2-ndt-4-1111"><label>2</label> Departments of Anatomy and Neurobiology and Surgery (Neurosurgery), Dalhousie University, Halifax, Nova Scotia, Canada</aff><author-notes><corresp id="c1-ndt-4-1111">Correspondence: Ivar Mendez, Room 3806, Division of Neurosurgery, Queen Elizabeth II Health Sciences Centre, 1796 Summer Street, Halifax, Nova Scotia, Canada B3H 4A7, Tel +1 902 473 7046, Fax +1 902 473 3343, Email<email>mendez@dal.ca</email></corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2008</year></pub-date><volume>4</volume><issue>6</issue><fpage>1111</fpage><lpage>1128</lpage><copyright-statement>&#x000a9; 2008 Dove Medical Press Limited. All rights reserved</copyright-statement><copyright-year>2008</copyright-year><abstract><p>Tourette&#x02019;s syndrome (TS) is a neurological disorder characterized by motor and vocal tics that typically begin in childhood and often are accompanied by psychiatric comorbidities. Symptoms of TS may be socially disabling and cause secondary medical complications. Pharmacological therapies remain the mainstay of symptom management. For the subset of patients in whom TS symptoms are medically recalcitrant and do not dissipate by adulthood, neurosurgery may offer an alternative treatment strategy. Greater understanding of the neuroanatomic and pathophysiologic basis of TS has facilitated the development of surgical procedures that aim to ameliorate TS symptoms by lesions or deep brain stimulation of cerebral structures. Herein, the rationale for the surgical management of TS is discussed and neurosurgical experiences since the 1960s are reviewed. The necessity for neurosurgical strategies to be performed with appropriate ethical considerations is highlighted.</p></abstract><kwd-group><kwd>tourette&#x02019;s syndrome</kwd><kwd>neurosurgery</kwd><kwd>deep brain stimulation</kwd><kwd>thalamus</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><sec><title>Historical perspective</title><p>In 1825, Jean-Marc Gaspard Itard, the Chief Physician at the National Institute for Deaf Mutes in Paris, provided careful clinical observations of stereotypic movements and vocalizations in the 26-year-old Marquise de Dampierre:</p><disp-quote><p>[she] began to have convulsive contractions in her hand and arm muscles, which manifested themselves especially at the moments in which this [woman as a] child tried to write as she spread her hand over the characters that she traced. After this deviation, her hand movements returned to normal once more and were subject to her will until another jolt interrupted the operation of her hand once more&#x02026;soon it became certain that these movements were involuntary and convulsive, as the muscles of the shoulders, the neck and the face participated in them. The malady continued to progress, spasms were propagated in the organs of the voice and of the speech, and this young woman uttered bizarre cries and words which made no sense (<xref ref-type="bibr" rid="b73-ndt-4-1111">Itard 1825</xref>).</p></disp-quote><p>The socially disabling effects of the disorder were also clear to Itard:</p><disp-quote><p>Among the continuous and disordered movements which lead to these morbid contractions, those imparted by the organs of voice and speech are the only ones deserving all our attention as presenting the more rare phenomenon as well as constituting the most disagreeable inconvenience, one which prevents the person from attaining all the kindnesses society offers; because the disorder that she bears is proportional to the pleasure of which it deprives her&#x02026;the more others seem revolted by her uncivilized statements, the more she is tormented by the fear of uttering them (<xref ref-type="bibr" rid="b23-ndt-4-1111">Itard 1825</xref>).</p></disp-quote><p>Although George Beard (1880&#x02013;1881) later described an additional fifty patients with motor tics and echolalia, the disorder was eponymously named by Jean-Martin Charcot after his student Georges Gilles de la Tourette, who had written a two-part manuscript in 1885 describing nine affected patients, including the Marquise (<xref ref-type="bibr" rid="b58-ndt-4-1111">Gilles de la Tourette 1885</xref>).</p></sec><sec><title>Clinical features of Tourette&#x02019;s syndrome</title><p>The clinical features of Tourette&#x02019;s syndrome (TS) as described by those original reports remain the basis for current diagnostic criteria. More specifically, both the Tourette Syndrome Classification Study Group and the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (<xref ref-type="bibr" rid="b145-ndt-4-1111">The Tourette Syndrome Classification Study Group 1993</xref>; <xref ref-type="bibr" rid="b105-ndt-4-1111">M&#x000fc;ller-Vahl 2002</xref>) currently require the presence of multiple motor and vocal tics (stereotyped, purposeless, and involuntary movements or sounds) daily or intermittently over the course of over one year, and with onset in childhood (prior to eighteen years of age for the DSM-IV). An additional essential diagnostic criterion is tic variability; that is, their severity, frequency, and affected anatomic location must vary over the course of the disorder (<xref ref-type="bibr" rid="b145-ndt-4-1111">The Tourette Syndrome Classification Study Group 1993</xref>).</p><p>Categorization of TS into subtypes according to the patient&#x02019;s symptoms has been proposed (<xref ref-type="bibr" rid="b128-ndt-4-1111">Shapiro et al 1988</xref>; <xref ref-type="bibr" rid="b116-ndt-4-1111">Robertson et al 1990</xref>; <xref ref-type="bibr" rid="b75-ndt-4-1111">Jankovic 2001</xref>). Simple TS is characterized by the predominance of motor and vocal tics, whereas more complex subtypes feature coprolalia, copropraxia, echolalia, echopraxia, palilalia, and/or palipraxia (<xref ref-type="bibr" rid="b116-ndt-4-1111">Robertson et al 1990</xref>; <xref ref-type="bibr" rid="b75-ndt-4-1111">Jankovic 2001</xref>). Patients with TS may also commonly exhibit other behavioral symptoms (<xref ref-type="bibr" rid="b57-ndt-4-1111">Gilbert 2006</xref>), such as attention deficit-hyperactivity disorder (<xref ref-type="bibr" rid="b119-ndt-4-1111">Robertson 2000</xref>), obsessive compulsive disorder (<xref ref-type="bibr" rid="b51-ndt-4-1111">Frankel et al 1986</xref>; <xref ref-type="bibr" rid="b36-ndt-4-1111">Como 1995</xref>), self-injurious behaviors (<xref ref-type="bibr" rid="b118-ndt-4-1111">Robertson et al 1989</xref>; <xref ref-type="bibr" rid="b85-ndt-4-1111">Kurlan et al 1990</xref>; <xref ref-type="bibr" rid="b87-ndt-4-1111">Leckman et al 1993</xref>; <xref ref-type="bibr" rid="b71-ndt-4-1111">Houeto et al 2005</xref>; <xref ref-type="bibr" rid="b6-ndt-4-1111">Anandan et al 2004</xref>; <xref ref-type="bibr" rid="b1-ndt-4-1111">Ackermans et al 2007</xref>), and/or anxiety disorders (<xref ref-type="bibr" rid="b119-ndt-4-1111">Robertson 2000</xref>).</p><p>Treatment of TS symptoms is pursued if the symptoms adversely affect quality of life or cause medical complications (<xref ref-type="bibr" rid="b133-ndt-4-1111">Singer 2001</xref>). Patients who exhibit mild symptoms may require only psychobehavioral therapies and the support of family, teachers, and TS support groups (<xref ref-type="bibr" rid="b83-ndt-4-1111">Kurlan 1997</xref>; <xref ref-type="bibr" rid="b105-ndt-4-1111">M&#x000fc;ller-Vahl 2002</xref>; <xref ref-type="bibr" rid="b150-ndt-4-1111">Visser-Vanderwalle 2007</xref>). Some patients may be able to avoid the use of pharmacological therapies since TS is unique as a hyperkinetic movement disorder in that patients describe the ability to suppress their tics (<xref ref-type="bibr" rid="b39-ndt-4-1111">Demirkiran and Jankovic 1995</xref>), at least in part. Moreover, although patients typically demonstrate a chronic disease course, symptom remission may occur spontaneously in up to 40% of patients by late adolescence and an additional 30% of patients may experience later symptom improvement (<xref ref-type="bibr" rid="b27-ndt-4-1111">Bruun and Budman 1992</xref>; <xref ref-type="bibr" rid="b89-ndt-4-1111">Leckman et al 1998</xref>; <xref ref-type="bibr" rid="b10-ndt-4-1111">Babel et al 2001</xref>). Pharmacological therapies may be beneficial for patients whose tics do not respond sufficiently to conservative treatments or are functionally incapacitating (<xref ref-type="bibr" rid="b57-ndt-4-1111">Gilbert 2006</xref>). The association of tics with medical or psychiatric conditions may necessitate more aggressive tic management. For example, TS has been associated with self-injurious behaviors requiring urgent medical attention (<xref ref-type="bibr" rid="b118-ndt-4-1111">Robertson et al 1989</xref>; <xref ref-type="bibr" rid="b85-ndt-4-1111">Kurlan et al 1990</xref>; <xref ref-type="bibr" rid="b87-ndt-4-1111">Leckman et al 1993</xref>; <xref ref-type="bibr" rid="b71-ndt-4-1111">Houeto et al 2005</xref>; <xref ref-type="bibr" rid="b6-ndt-4-1111">Anandan et al 2004</xref>; <xref ref-type="bibr" rid="b1-ndt-4-1111">Ackermans et al 2007</xref>), such as corneal and orbital injuries (<xref ref-type="bibr" rid="b116-ndt-4-1111">Robertson et al 1990</xref>) and stab wound- inflicted injuries (<xref ref-type="bibr" rid="b6-ndt-4-1111">Anandan et al 2004</xref>), or tic-induced medical complications, such as cervical myelopathy (Krauss and Jankovic 1996), limb fractures, and retinal detachments (<xref ref-type="bibr" rid="b50-ndt-4-1111">Flaherty et al 2005</xref>). The variety of medications used to manage TS has included dopaminergic antagonists, benzodiazepines, calcium channel antagonists, and atypical neuroleptics (<xref ref-type="bibr" rid="b83-ndt-4-1111">Kurlan 1997</xref>; <xref ref-type="bibr" rid="b117-ndt-4-1111">Robertson and Stern 2000</xref>; <xref ref-type="bibr" rid="b76-ndt-4-1111">Jim&#x000e9;nez-Jim&#x000e9;nez and Garc&#x000ed;a-Ruiz 2001</xref>; <xref ref-type="bibr" rid="b105-ndt-4-1111">M&#x000fc;ller-Vahl 2002</xref>). Botulinum toxin injections have been used to treat painful dystonic tics (<xref ref-type="bibr" rid="b74-ndt-4-1111">Jankovic 1994</xref>). Medical therapies may be particularly useful even during the waning phase of tics in early adolescence since tics have been reported to worsen at that time before they may ultimately resolve (<xref ref-type="bibr" rid="b89-ndt-4-1111">Leckman et al 1998</xref>). However, medical therapies may cause detrimental and intolerable side effects (<xref ref-type="bibr" rid="b90-ndt-4-1111">Leckman 2002</xref>; <xref ref-type="bibr" rid="b50-ndt-4-1111">Flaherty et al 2005</xref>) and, for a subset of patients with TS, are ineffective (<xref ref-type="bibr" rid="b105-ndt-4-1111">M&#x000fc;ller-Vahl 2002</xref>; <xref ref-type="bibr" rid="b150-ndt-4-1111">Visser-Vandewalle 2007</xref>). As <xref ref-type="bibr" rid="b79-ndt-4-1111">Kopell and colleagues (2003)</xref> note, the development of additional treatment strategies for this subset of patients is particularly important given that the endpoint for unsatisfactorily managed neuropsychiatric disease is &#x0201c;dismal&#x0201d;.</p></sec></sec><sec><title>Pathophysiology of Tourette&#x02019;s syndrome</title><sec><title>Anatomical studies</title><p>The development of surgical strategies for medically recalcitrant TS was enabled by efforts to localize an anatomical source of the symptoms. Psychodynamic theories prior to the 1970s sought to explain tics as resulting from suppressed aggression and &#x0201c;impaired functioning of the &#x02018;motility controlling function of the ego&#x02019; &#x0201d; (Mahler and Luke 1946;Flinn et al 1983). Autopsy findings from patients with TS that demonstrated no specific anatomical pathologies or only subtle changes in the striatum seemed to support conceptions that tics had a psychogenic origin (<xref ref-type="bibr" rid="b41-ndt-4-1111">DeWulf and van Bogaert 1941</xref>; <xref ref-type="bibr" rid="b14-ndt-4-1111">Balthasar 1957</xref>). The search for an anatomical basis for TS using autopsy material is thought to be problematic, however, both because few post-mortem brains have been studied and most of those available have come from patients with long-standing disease and treatment that might confound the histological analyses (<xref ref-type="bibr" rid="b100-ndt-4-1111">Mink et al 2001</xref>; <xref ref-type="bibr" rid="b53-ndt-4-1111">Frey et al 2006</xref>). Nevertheless, more recent studies have found abnormalities particularly in the basal ganglia and frontal cortex. For example, studies have reported decreased levels of dynorphin-like immunoreactivity in the striatum and globus pallidus (<xref ref-type="bibr" rid="b62-ndt-4-1111">Haber et al 1986</xref>; <xref ref-type="bibr" rid="b63-ndt-4-1111">Haber and Wolfer 1992</xref>), decreased subcortical levels of serotonin (<xref ref-type="bibr" rid="b7-ndt-4-1111">Anderson et al 1992</xref>), increased numbers of neurons expressing parvalbumin in the globus pallidus pars internus (GPi) and decreased numbers of neurons expressing parvalbumin in the caudate nucleus and globus pallidus pars externus (GPe) (<xref ref-type="bibr" rid="b77-ndt-4-1111">Kalanithi et al 2005</xref>). Interestingly, Itard had speculated that the symptoms of TS had a cerebral origin in his 1825 case report:</p><disp-quote><p>What is the nature of these strange convulsions, or to pose the question in a clearer manner, the seat of the irritation which provokes them? Considering that the muscles which move against the will belong to different motor apparatuses which are not managed by the same nerves, this irritation is not caused by any of them but at their common centre which is the brain.</p></disp-quote></sec><sec><title>Neuroimaging studies</title><p>Modern imaging studies lend further evidence for a neuroanatomic basis of TS. Asymmetric striatal volumes have been observed in magnetic resonance images (MRI) of patients with TS, with smaller striatal volumes suggesting abnormalities in striatal development or the loss of GABAergic interneurons that are thought to play a role in gating sensory information (<xref ref-type="bibr" rid="b114-ndt-4-1111">Peterson et al 1993</xref>; <xref ref-type="bibr" rid="b131-ndt-4-1111">Singer et al 1993</xref>). Abnormally smaller caudate volumes are thought to be predictive of the development of more severe tics in early adulthood (<xref ref-type="bibr" rid="b24-ndt-4-1111">Bloch et al 2005</xref>) and have been associated with more severe symptoms in twin studies (<xref ref-type="bibr" rid="b72-ndt-4-1111">Hyde et al 1995</xref>). Abnormalities of volume also have been observed in the lenticular nuclei (<xref ref-type="bibr" rid="b114-ndt-4-1111">Peterson et al 1993</xref>; <xref ref-type="bibr" rid="b131-ndt-4-1111">Singer et al 1993</xref>). These findings are inconsistent, however, since other studies have found no significant differences in basal ganglia nuclei volumes compared to those of normal control patients (<xref ref-type="bibr" rid="b104-ndt-4-1111">Moriarty et al 1997</xref>; <xref ref-type="bibr" rid="b155-ndt-4-1111">Zimmerman et al 2000</xref>), or have found increased caudate volumes in children with TS (<xref ref-type="bibr" rid="b40-ndt-4-1111">Denkla et al 1991</xref>). Functional MRI has revealed activity in the neocortex, striatum, thalamus, parietal operculum, supplementary motor area, insular cortex, and cerebellum in association with tic generation (<xref ref-type="bibr" rid="b115-ndt-4-1111">Peterson 2001</xref>; <xref ref-type="bibr" rid="b26-ndt-4-1111">Bohlhalter et al 2006</xref>; <xref ref-type="bibr" rid="b91-ndt-4-1111">Lerner et al 2007</xref>), while increased activity in the caudate and frontal and temporal cortices and decreased activity in the ventral GP, putamen and thalamus have been observed during tic suppression (<xref ref-type="bibr" rid="b115-ndt-4-1111">Peterson 2001</xref>). Increased activation of the substantia nigra, ventral tegmental area, and basal ganglia structures of the direct pathway has also been associated with increased tic severity in nonmedicated children with TS (<xref ref-type="bibr" rid="b15-ndt-4-1111">Baym et al 2008</xref>). Positron emission tomography (PET) studies using <sup>18</sup>F-fluorodeoxyglucose in patients with TS demonstrate increased metabolic activity in the premotor and supplementary cortices and midbrain and concomitant decreased activity in the caudate and thalamus (<xref ref-type="bibr" rid="b137-ndt-4-1111">Stoetter et al 1992</xref>; <xref ref-type="bibr" rid="b45-ndt-4-1111">Eidelberg et al 1997</xref>) while in those studies using <sup>15</sup>O-water found increased activity in cerebral regions associated with sensorimotor, language, executive and paralimbic functions, which was temporally related to both the expression of motor and phonic tics and their premonitory urges (<xref ref-type="bibr" rid="b135-ndt-4-1111">Stern et al 2000</xref>). Finally, consistent with PET findings of decreased glucose utilization, single photon emission tomography (SPECT) has revealed decreased regional blood perfusion of the basal ganglia, thalamus, and frontal and temporal cortices in TS (<xref ref-type="bibr" rid="b114-ndt-4-1111">Peterson et al 1993</xref>).</p><p>Anatomic localization of TS symptom generation to the basal ganglia is consistent with current understanding of basal ganglia physiology. In a general sense, disordered cortico-striato-pallido-thalamo-cortical circuitry is thought to be etiologically-related to TS, although the specific nuclei and circuits responsible for the various symptoms remain a matter of continued investigation (<xref ref-type="bibr" rid="b105-ndt-4-1111">M&#x000fc;ller-Vahl 2002</xref>; <xref ref-type="bibr" rid="b101-ndt-4-1111">Mink et al 2006</xref>). It has been suggested, for example, that simple motor tics could be due to abnormal activation of the motor cortex via thalamocortical pathways while involvement of premotor, supplementary motor, and cingulate cortices may be related to more complex motor tics (<xref ref-type="bibr" rid="b135-ndt-4-1111">Stern et al 2000</xref>; <xref ref-type="bibr" rid="b100-ndt-4-1111">Mink et al 2001</xref>). Inappropriate activity in Broca&#x02019;s area, the frontal operculum, and the caudate nucleus could elicit vocal tics (<xref ref-type="bibr" rid="b135-ndt-4-1111">Stern et al 2000</xref>; <xref ref-type="bibr" rid="b100-ndt-4-1111">Mink et al 2001</xref>). Abnormal activation of the orbitofrontal region, which has been observed in obsessive compulsive disorder, may underlie the compulsions and urges that patients with TS experience (<xref ref-type="bibr" rid="b135-ndt-4-1111">Stern et al 2000</xref>; <xref ref-type="bibr" rid="b100-ndt-4-1111">Mink et al 2001</xref>). Alternatively, tics in TS may be due to abnormal activity within subsets of neurons within the caudate and putamen (<xref ref-type="bibr" rid="b61-ndt-4-1111">Graybiel et al 1994</xref>; <xref ref-type="bibr" rid="b100-ndt-4-1111">Mink et al 2001</xref>); indeed, microstimulation of discrete areas of the putamen in monkeys induces stereotypic movements akin to tics (<xref ref-type="bibr" rid="b5-ndt-4-1111">Alexander et al 1985</xref>).</p></sec><sec><title>Neurotransmitter studies</title><p>Given the diversity of nuclei and circuits that may be involved in TS pathogenesis, the variety of neurotransmitter systems that are also implicated is not surprising (<xref ref-type="bibr" rid="b75-ndt-4-1111">Jankovic 2001</xref>). In the frontal subcortical circuits alone, abnormalities in glutamate, dopamine, serotonin, GABA, acetylcholine, noradrenaline, opioid, and cannabinoid receptors are thought to be involved (<xref ref-type="bibr" rid="b86-ndt-4-1111">Lavenstein et al 2003</xref>). The serotonergic system has been studied in particular: patients with TS have been found to have decreased levels of serotonin and its metabolite 5-hydroxyindoleacetic acid in their serum (<xref ref-type="bibr" rid="b35-ndt-4-1111">Comings 1990</xref>) and cerebrospinal fluid (<xref ref-type="bibr" rid="b28-ndt-4-1111">Butler et al 1979</xref>), respectively, and post-mortem studies have found decreased serotonin levels in the brain stem (<xref ref-type="bibr" rid="b142-ndt-4-1111">Swerdlow and Young 2001</xref>). This latter finding is particularly relevant since serotonergic projections from the medial raphe nucleus are known to project to regions implicated in tic generation, such as the prefrontal cortex, substantia nigra pars compacta, ventral tegmental area, striatum, and nucleus accumbens (<xref ref-type="bibr" rid="b4-ndt-4-1111">Alex et al 2005</xref>; <xref ref-type="bibr" rid="b113-ndt-4-1111">Pehek et al 2006</xref>). These target structures are components of the dopaminergic system and, thus, it has been hypothesized that it is not serotonergic dysfunction, <italic>per se</italic>, that induces tics, but rather its effects on the dopaminergic system (<xref ref-type="bibr" rid="b69-ndt-4-1111">Harris et al 2006</xref>). Serotonin influences dopaminergic release via a number of receptors, including serotonin heteroreceptors and inhibitory and stimulatory somatodendritic receptors, and is involved in dopamine reuptake (<xref ref-type="bibr" rid="b125-ndt-4-1111">Sershen et al 2000</xref>; <xref ref-type="bibr" rid="b4-ndt-4-1111">Alex et al 2005</xref>; <xref ref-type="bibr" rid="b113-ndt-4-1111">Pehek et al 2006</xref>; <xref ref-type="bibr" rid="b31-ndt-4-1111">Carta et al 2007</xref>).</p><p>Indeed, the most widely purported hypothesis to explain the etiology of TS concerns dopaminergic circuitry dysfunction. The ability of dopaminergic antagonists to suppress tics suggests that the dopaminergic system is hyperactive in TS (<xref ref-type="bibr" rid="b75-ndt-4-1111">Jankovic 2001</xref>). The direct dopaminergic basal ganglia pathway is thus facilitated, and the indirect pathway inhibited, which results in thalamocortical over-activity (<xref ref-type="bibr" rid="b150-ndt-4-1111">Visser-Vandewalle 2007</xref>; <xref ref-type="fig" rid="f1-ndt-4-1111">Figure 1</xref>). Dopaminergic hyperactivity could arise due to alterations in dopamine release (<xref ref-type="bibr" rid="b134-ndt-4-1111">Snyder et al 1970</xref>; <xref ref-type="bibr" rid="b130-ndt-4-1111">Singer et al 1982</xref>; <xref ref-type="bibr" rid="b69-ndt-4-1111">Harris et al 2006</xref>). Imaging studies In TS suggest an &#x0201c;overactive DAT [dopamine transporter] system&#x0201d; (<xref ref-type="bibr" rid="b69-ndt-4-1111">Harris et al 2006</xref>): for example, SPECT has demonstrated increased dopamine transporter binding in the striatum in patients with TS (<xref ref-type="bibr" rid="b34-ndt-4-1111">Cheon et al 2004</xref>; <xref ref-type="bibr" rid="b124-ndt-4-1111">Serra-Mestres et al 2004</xref>), suggesting an elevated density of presynaptic dopamine terminals and postsynaptic D2 dopamine receptors, particularly in the ventral striatum (<xref ref-type="bibr" rid="b153-ndt-4-1111">Wong et al 1989</xref>; <xref ref-type="bibr" rid="b46-ndt-4-1111">Ernst et al 1999</xref>; <xref ref-type="bibr" rid="b152-ndt-4-1111">Wolf et al 1996</xref>; <xref ref-type="bibr" rid="b3-ndt-4-1111">Albin et al 2003</xref>). In further study of D2 receptors using <sup>11</sup>C raclopride PET, amphetamine challenge caused a 21% increase in intrasynaptic dopamine levels that was not observed in control patients (<xref ref-type="bibr" rid="b132-ndt-4-1111">Singer et al 2002</xref>). Although D2 receptor density has correlated with TS symptom intensity in monozygotic twins (<xref ref-type="bibr" rid="b152-ndt-4-1111">Wolf et al 1996</xref>), this has not been consistently observed (<xref ref-type="bibr" rid="b154-ndt-4-1111">Wong et al 1997</xref>). The net result of increased DAT density is decreased tonic extracellular levels of dopamine, increased dopamine levels in the axon terminal, and dopamine receptor supersensitivity (reviewed in <xref ref-type="bibr" rid="b69-ndt-4-1111">Harris et al 2006</xref>). Alternatively, TS may result not from abnormalities of dopaminergic transmission but from changes in the resting membrane potentials of striatal neurons whose response to dopamine is consequently affected (<xref ref-type="bibr" rid="b100-ndt-4-1111">Mink et al 2001</xref>).</p></sec><sec><title>Animal studies</title><p>Animal models have been developed to better understand the pathophysiologic basis of TS (<xref ref-type="bibr" rid="b140-ndt-4-1111">Swerdlow and Sutherland 2005</xref>, <xref ref-type="bibr" rid="b141-ndt-4-1111">2006</xref>). Normally, a prestimulus can prevent a startle response elicited by a stimulus, but this has been found to be deficient in TS (<xref ref-type="bibr" rid="b32-ndt-4-1111">Castellanos et al 1996</xref>; <xref ref-type="bibr" rid="b52-ndt-4-1111">Freudenberg et al 2007</xref>). This is thought to be due to deficient &#x0201c;gating&#x0201d; of sensorimotor information and has been modelled in rodents, pigs, and nonhuman primates (<xref ref-type="bibr" rid="b139-ndt-4-1111">Swerdlow et al 2001</xref>; <xref ref-type="bibr" rid="b140-ndt-4-1111">Swerdlow and Sutherland 2005</xref>; <xref ref-type="bibr" rid="b52-ndt-4-1111">Freudenberg et al 2007</xref>; <xref ref-type="bibr" rid="b64-ndt-4-1111">Hadamitzky et al 2007</xref>). In order to model the hyperactive basal ganglia and limbic circuitry thought to underlie TS, transgenic mice have been developed that have tonically hyperactive cortical and limbic circuits (<xref ref-type="bibr" rid="b29-ndt-4-1111">Campbell et al 2000</xref>; <xref ref-type="bibr" rid="b98-ndt-4-1111">McGrath et al 2000</xref>; <xref ref-type="bibr" rid="b108-ndt-4-1111">Nordstrom and Burton 2002</xref>; <xref ref-type="bibr" rid="b140-ndt-4-1111">Swerdlow and Sutherland 2005</xref>,2007). These rodents display tics as well as compulsive behaviors (<xref ref-type="bibr" rid="b29-ndt-4-1111">Campbell et al 2000</xref>; <xref ref-type="bibr" rid="b98-ndt-4-1111">McGrath et al 2000</xref>; <xref ref-type="bibr" rid="b108-ndt-4-1111">Nordstrom and Burton 2002</xref>; <xref ref-type="bibr" rid="b140-ndt-4-1111">Swerdlow and Sutherland 2005</xref>, 2007). Micro- injection of the GABA<sub>A</sub> antagonist bicuculline in the limbic area of the GPe has also been shown to induce complex tics and compulsions in African green monkeys and may therefore provide an additional primate model of TS (<xref ref-type="bibr" rid="b60-ndt-4-1111">Grabli et al 2004</xref>). In addition to enhancing understanding of abnormal TS neural circuitries, animal models could be used to test surgical therapies before they are introduced to the clinical setting.</p></sec></sec><sec><title>Neurosurgical lesions</title><sec><title>Frontal lobe disconnection</title><p>Surgical disruption of basal ganglia circuits began to be employed for the treatment of TS in 1955 (<xref ref-type="bibr" rid="b136-ndt-4-1111">Stevens 1964</xref>; <xref ref-type="fig" rid="f2-ndt-4-1111">Figure 2</xref>, <xref ref-type="table" rid="t1-ndt-4-1111">Table 1</xref>). The earliest studies focused on surgical disconnection of the frontal lobe. <xref ref-type="bibr" rid="b136-ndt-4-1111">Stevens (1964)</xref> reported the details of the prefrontal lobotomy that James Watts had performed nine years earlier in a 37-year-old man who had become incapacitated due to his motor and vocal tics. Two years post-operatively, the patient demonstrated improvement in his symptoms, which persisted for at least an additional six years. His beneficial clinical course could not be attributed entirely to the surgery, however, since he also began to use neuroleptics. <xref ref-type="bibr" rid="b12-ndt-4-1111">Baker (1962)</xref> reported the apparently successful management of tics and panic attacks in a 22-year-old man with bimedial frontal leucotomy, but <xref ref-type="bibr" rid="b102-ndt-4-1111">Moldofsky and colleagues&#x02019; (1974)</xref> found that these benefits did not persist. The longest reported duration of symptom control attributed to prefrontal leucotomy was that experienced by a 29-year-old man with TS in whom there was complete resolution of motor and vocal tics beginning five years post-operatively and for thirty-three years thereafter (<xref ref-type="bibr" rid="b82-ndt-4-1111">Kulisevsky et al 1995</xref>). Measurement of regional cerebral blood flow using <sup>99</sup>Tc-hexamethlypropylene amine oxide SPECT showed bilateral frontal hypoperfusion (<xref ref-type="bibr" rid="b82-ndt-4-1111">Kulisevsky et al 1995</xref>).</p></sec><sec><title>Cingulotomy</title><p>Demonstration of the efficacy of frontal lobotomy procedures for TS was not clear, and as a result procedures that targeted the cingulate cortex were investigated as an alternative. Anterior cingulotomy had been used since 1948 to treat a variety of psychiatric disorders to disconnect neural circuits involving the cortex, limbic system, and basal ganglia (<xref ref-type="bibr" rid="b151-ndt-4-1111">Whitty et al 1952</xref>; <xref ref-type="bibr" rid="b13-ndt-4-1111">Ballantine et al 1987</xref>). Targeting the cingulate cortex for the treatment of TS seemed appropriate given its recognized role in mediating emotional experiences and language and coordinated movements (<xref ref-type="bibr" rid="b116-ndt-4-1111">Robertson et al 1990</xref>). Cingulotomy decreased tics by 75% by 2 years post-operatively in one patient (<xref ref-type="bibr" rid="b6-ndt-4-1111">Anandan et al 2004</xref>) and provided enduring improvement in another (<xref ref-type="bibr" rid="b123-ndt-4-1111">Sawle et al 1993</xref>). In an imaging study that found normalization of preoperative hypermetabolism in the caudate nucleus and thalamus, the beneficial effects of cingulotomy were ascribed nonspecifically to the disruption of abnormal basal ganglia-thalamocortical circuitry (<xref ref-type="bibr" rid="b123-ndt-4-1111">Sawle et al 1993</xref>). Other case reports have not confirmed those beneficial effects of cingulotomy and found that the procedure had little effects on reducing either tic severity or frequency or seemed more efficacious for other comorbid symptoms, such as SIB and OCD (<xref ref-type="bibr" rid="b84-ndt-4-1111">Kurlan et al 1988</xref>, <xref ref-type="bibr" rid="b85-ndt-4-1111">1990</xref>; <xref ref-type="bibr" rid="b116-ndt-4-1111">Robertson et al 1990</xref>; <xref ref-type="bibr" rid="b11-ndt-4-1111">Baer et al 1994</xref>). <xref ref-type="bibr" rid="b17-ndt-4-1111">Beckers (1973)</xref> has recommended against the use of cingulotomy because of its side effects, which have included the development of apathy, intellectual impairment, and difficulties with concentration.</p></sec><sec><title>Thalamotomy</title><p>Attenuation of the corticostriatal hyperactivity that is thought to underlie TS symptomatology has also been attempted by thalamic lesions. Cooper&#x02019;s performance of a right and then, one year later, left chemothalamectomy in a 16-year-old girl with TS significantly improved her tic frequency (Cooper 1962) and he later described his experience with thalamic lesions in six other patients with TS (Cooper 1969). Details for only one representative case were provided, in which surgery had no effect on the tics. The results of <xref ref-type="bibr" rid="b70-ndt-4-1111">Hassler and Dieckeman (1970)</xref> were more promising: up to 14 coagulations were made stereotactically in each hemisphere in the medial, intralaminar, and ventrolateral thalamic nuclei and between 70% and 100% subjective improvement of tic symptomatology was observed. The same nuclei have been targeted in 4 other reported patients, but complete tic resolution was observed in only one patient, and in the others tic improvement was only transient at best (<xref ref-type="bibr" rid="b38-ndt-4-1111">de Divitiis et al 1977</xref>; <xref ref-type="bibr" rid="b30-ndt-4-1111">Cappabianca et al 1987</xref>). A case report in which bilateral cingulotomies and infrathalamic lesions were made highlights the potential devastating complications of thalamic lesions (<xref ref-type="bibr" rid="b87-ndt-4-1111">Leckman et al 1993</xref>). A 40-year-old man who underwent these procedures demonstrated improvement of obsessive compulsive symptoms but persistence of motor and vocal and the left lesions were therefore repeated (<xref ref-type="bibr" rid="b87-ndt-4-1111">Leckman et al 1993</xref>). The infrathalamic lesion was extended inferiorly within the red nucleus and included as well the H fields of Forel, the basal intralaminar nucleus of the thalamus, the subthalamic nucleus, efferent fibres from the VTA and SNr, and the dentatorubrothalamic efferent fibres from the cerebellum (<xref ref-type="bibr" rid="b87-ndt-4-1111">Leckman et al 1993</xref>). Post-operatively the patient developed a number of severe neurological deficits including dysarthria, dysphagia, gait and hand-writing difficulties, mild hemiparesis, abnormal extraocular movements, axial rigidity, and bradykinesia (<xref ref-type="bibr" rid="b87-ndt-4-1111">Leckman et al 1993</xref>).</p></sec><sec><title>Lesions of other structures</title><p>Stereotaxy has facilitated the targeting of other deep-seated cerebral structures for the treatment of TS. In combination with lesions of the lamella medialis and ventrolateral nuclei of the thalamus, the zona incerta has been lesioned with significant reduction of tic severity (<xref ref-type="bibr" rid="b10-ndt-4-1111">Babel et al 2001</xref>). Transient and permanent deficits were experienced by 66% and 27% of patients (<xref ref-type="bibr" rid="b10-ndt-4-1111">Babel et al 2001</xref>), with bilateral lesions carrying a higher risk of neurological morbidity, including hemiballism, dystonia, dysarthria (<xref ref-type="bibr" rid="b10-ndt-4-1111">Babel et al 2001</xref>), and quadriplegia (<xref ref-type="bibr" rid="b9-ndt-4-1111">Asam and Karrass 1981</xref>). Other structures targeted include the anterior limb of the internal capsule (<xref ref-type="bibr" rid="b138-ndt-4-1111">Sun et al 2005</xref>), within which striatal circuits and circuits that connect orbitofrontal cortical and medial thalamic nuclei pass. Lesions of the posterior third of the anterior internal capsule provided more durable improvement of symptoms, which was thought to be due the greater efficacy of posterior lesions to disrupt neural pathways connecting the basal ganglia and frontal cortex (<xref ref-type="bibr" rid="b138-ndt-4-1111">Sun et al 2005</xref>). In one case report, lesions of the dentate nucleus reportedly attenuated motor and vocal tics, but neither rationale for targeting this cerebellar structure nor a proposed mechanism of beneficial action were discussed (<xref ref-type="bibr" rid="b106-ndt-4-1111">N&#x000e1;dvorn&#x000ed;k et al 1972</xref>).</p></sec></sec><sec><title>Deep brain stimulation</title><p>Although neurosurgical lesions for TS have ameliorated symptoms for some patients, for others, benefits have not been apparent and lesions have been associated with a number of permanent and disabling side effects. Deep brain stimulation (DBS) emerged as a promising alternative therapeutic strategy to stereotactic lesions after its efficacy in the treatment of tremor was demonstrated in 1987 (<xref ref-type="bibr" rid="b18-ndt-4-1111">Benabid et al 1987</xref>). The similar clinical effects of lesions and high frequency stimulation (HFS) suggest that DBS may inhibit the activity of target structures, by depolarization blockade, synaptic inhibition, and/or the release of inhibitory neurotransmitters (<xref ref-type="bibr" rid="b20-ndt-4-1111">Benazzouz and Hallet 2000</xref>; <xref ref-type="bibr" rid="b44-ndt-4-1111">Dostrovsky et al 2002</xref>; <xref ref-type="bibr" rid="b48-ndt-4-1111">Filali et al 2004</xref>; <xref ref-type="bibr" rid="b94-ndt-4-1111">Lozano and Mahat 2004</xref>; <xref ref-type="bibr" rid="b99-ndt-4-1111">McIntyre et al 2004</xref>; <xref ref-type="bibr" rid="b33-ndt-4-1111">Chang et al 2008</xref>; <xref ref-type="bibr" rid="b93-ndt-4-1111">Liu et al 2008</xref>; <xref ref-type="bibr" rid="b103-ndt-4-1111">Montgomery and Gale 2008</xref>). Other studies suggest, however, that DBS has an excitatory effect on neurons and axonal pathways in the vicinity of the electrode (<xref ref-type="bibr" rid="b99-ndt-4-1111">McIntyre et al 2004</xref>; <xref ref-type="bibr" rid="b33-ndt-4-1111">Chang et al 2008</xref>; <xref ref-type="bibr" rid="b93-ndt-4-1111">Liu et al 2008</xref>; <xref ref-type="bibr" rid="b103-ndt-4-1111">Montgomery and Gale 2008</xref>), or that DBS works by modulating the pattern of neuronal firing (<xref ref-type="bibr" rid="b54-ndt-4-1111">Fukada et al 2001</xref>; <xref ref-type="bibr" rid="b56-ndt-4-1111">Garcia et al 2005</xref>;Change et al 2008; <xref ref-type="bibr" rid="b93-ndt-4-1111">Liu et al 2008</xref>; <xref ref-type="bibr" rid="b103-ndt-4-1111">Montgomery and Gale 2008</xref>). Regardless of its mechanism of action, compared to lesion procedures DBS has the advantage of being both reversible (since the electrodes can be removed if HFS ineffectively treats symptoms) and adjustable (since the stimulation parameters can be varied to elicit the most optimal clinical response). <xref ref-type="bibr" rid="b19-ndt-4-1111">Benabid (2007)</xref> has thus referred to DBS as a &#x0201c;flexible scalpel.&#x0201d;</p><sec><title>Thalamic stimulation</title><p>Based upon the reported success of thalamic lesions in the control of TS symptoms, <xref ref-type="bibr" rid="b149-ndt-4-1111">Visser-Vandewalle and colleagues (1999)</xref> performed HFS of the thalamus in a 42-year-old man with medically recalcitrant TS (<xref ref-type="table" rid="t2-ndt-4-1111">Table 2</xref>). They found that HFS of the thalamic targets of <xref ref-type="bibr" rid="b70-ndt-4-1111">Hassler and Dieckemann (1970)</xref> significantly reduced the number of tics by 4 months post-operatively, with complete resolution of the tics after 1 year. Clinical benefits were ascribed to deactivation of frontal cortical areas (via stimulation of the nucleus ventro-oralis internus) and corticostriatal circuits that involve the ventral (limbic) and dorsal (sensorimotor) striatum (via stimulation of intralaminar and medial thalamic nuclei). In a subsequent study in which three patients were followed up to five years post-operatively, thalamic DBS was associated with a 72%, 83%, and 90% decrease in tics with complete resolution of all major vocal and motor tics (<xref ref-type="bibr" rid="b148-ndt-4-1111">Visser-Vandewalle et al 2003</xref>). Side effects of HFS included a slight sedative effect in all three patients and changes in sexual behavior in two (<xref ref-type="bibr" rid="b148-ndt-4-1111">Visser-Vandewalle et al 2003</xref>). <xref ref-type="bibr" rid="b126-ndt-4-1111">Servello and colleagues (2008)</xref> confirmed the therapeutic efficacy of thalamic DBS, albeit using targets different than those used by Visser-Vandewalle and colleagues, in their case series of eighteen patients in whom the centromedian-parafascicular and ventral oral thalamic nuclei were targeted. All patients demonstrated improvement in all four components of the Yale Global Tic Severity Rating Scale (YGTSS). By six months post-operatively, 3 patients&#x02019; tics had improved to the extent that they no longer required any adjunctive medical therapy. None of the patients experienced any disabling permanent side effects, but twelve patients required HFS adjustments. The ability for the effects of DBS to be tested in a double-blind manner was utilized in a recent prospective crossover trial (<xref ref-type="bibr" rid="b96-ndt-4-1111">Maciunas et al 2007</xref>). Patients in whom bilateral thalamic DBS electrodes were implanted were assessed over four weeks, with one week spent in each of the following DBS states: both stimulators off, unilateral stimulation on the left or right, or bilateral stimulation (<xref ref-type="bibr" rid="b96-ndt-4-1111">Maciunas et al 2007</xref>). The study&#x02019;s primary and secondary outcome measures were met in that all patients demonstrated significant improvements in Rush Video-Based Rating Scale (RVBRS) scores as well as YGTSS and TS Symptom List scores (<xref ref-type="bibr" rid="b96-ndt-4-1111">Maciunas et al 2007</xref>). <xref ref-type="bibr" rid="b1-ndt-4-1111">Ackermans and colleagues&#x02019; (2007)</xref> case report highlights that significant adverse effects can occur due to the thalamic DBS. Their 39-year-old patient developed a vertical gaze paralysis due to hemorrhage in the upper mesencephalon at the caudal tip of one of the electrodes.</p></sec><sec><title>Pallidal stimulation</title><p>Attenuation of thalamic activity, indirectly, has also been attempted by HFS of the GPi in order to inhibit its pathological over-activity that is thought to ultimately lead to disinhibition of the thalamus and, thus, tics (<xref ref-type="bibr" rid="b146-ndt-4-1111">van der Linden et al 2002</xref>; <xref ref-type="bibr" rid="b42-ndt-4-1111">Diederich et al 2005</xref>; <xref ref-type="bibr" rid="b71-ndt-4-1111">Houeto et al 2005</xref>; <xref ref-type="bibr" rid="b2-ndt-4-1111">Ackermans et al 2006</xref>; <xref ref-type="bibr" rid="b55-ndt-4-1111">Gallagher et al 2006</xref>; <xref ref-type="bibr" rid="b127-ndt-4-1111">Shahed et al 2007</xref>). <xref ref-type="bibr" rid="b146-ndt-4-1111">van der Linden and colleagues (2002)</xref> found that bilateral GPi DBS decreased tics by 95% in a 27-year-old man with long-standing TS, which was greater than the suppression of tics induced by medial thalamic DBS (80%), an effect that lasted at least six months. The efficacy of thalamic or pallidal DBS was found to be similar in another case report, although tic attenuation occurred more abruptly with pallidal stimulation (<xref ref-type="bibr" rid="b2-ndt-4-1111">Ackermans et al 2006</xref>). <xref ref-type="bibr" rid="b71-ndt-4-1111">Houeto and colleagues (2005)</xref> also directly compared the efficacy of pallidal versus thalamic DBS in their prospective double blind study. In one patient in whom electrodes were placed in the anteromedial GPi and centromedian-parafascicular complex of the thalamus, either thalamic or pallidal stimulation significantly reduced tic severity and SIB to a similar extent. Symptoms relating to mood and impulsivity were better controlled by thalamic DBS, however. <xref ref-type="bibr" rid="b42-ndt-4-1111">Diederich and colleagues (2005)</xref> provide up to fourteen months of follow-up data regarding their patient with bilateral DBS of the posteroventrolateral GPi. Tic frequency and intensity improved, as did the patient&#x02019;s concomitant anxious and depressive symptoms. These beneficial effects have been observed in two other case reports (<xref ref-type="bibr" rid="b55-ndt-4-1111">Gallagher et al 2006</xref>; <xref ref-type="bibr" rid="b127-ndt-4-1111">Shahed et al 2007</xref>).</p></sec><sec><title>Other targets for stimulation therapy</title><p>Other less frequently targeted structures include the anterior limb of the internal capsule and the nucleus accumbens (<xref ref-type="bibr" rid="b50-ndt-4-1111">Flaherty et al 2005</xref>; <xref ref-type="bibr" rid="b81-ndt-4-1111">Kuhn et al 2007</xref>). Using a more lateral and anterior target than has been used for the surgical treatment of OCD, DBS of the anterior limb of the internal capsule has been shown to decrease tic severity and frequency, but not to the extent that has been observed with thalamic DBS (<xref ref-type="bibr" rid="b50-ndt-4-1111">Flaherty et al 2005</xref>). Stimulation of the electrode&#x02019;s middle contacts resulted in the greatest improvement of tic symptomatology (<xref ref-type="bibr" rid="b50-ndt-4-1111">Flaherty et al 2005</xref>). Interestingly, variation in voltage parameters affected the patient&#x02019;s mood: HFS in the middle or dorsal-most contacts, which lay in the body of internal capsule, produced euthymia and hypomania, respectively, whereas stimulation of the ventral-most contacts, which was located near the nucleus accumbens, caused depression (<xref ref-type="bibr" rid="b50-ndt-4-1111">Flaherty et al 2005</xref>). <xref ref-type="bibr" rid="b81-ndt-4-1111">Kuhn and colleagues (2007)</xref> did not report any alteration of mood in their case report of HFS of the anterior limb of the internal capsule and fundus subventricularis of the nucleus accumbens, and found that it decreased their 26-year-old patient&#x02019;s YGTSS and RVBRS scores by 41% and 50%, respectively.</p></sec><sec><title>DBS caveats</title><p>Despite their therapeutic promise for TS and apparent advantages compared with neurosurgical lesion procedures, DBS strategies also can be associated with a number of deleterious side effects and complications. While certain adverse events are common to both lesion and DBS procedures, such as intracerebral hemorrhage<xref ref-type="fn" rid="fn1-ndt-4-1111">1</xref> and the development of surgery-related infection or seizures (<xref ref-type="bibr" rid="b68-ndt-4-1111">Hardesty and Sackheim 2007</xref>), others are unique to DBS. For example, patients with TS in whom DBS systems have been implanted have experienced poor healing, infections, or hardware malfunctions due to compulsions to repeatedly touch their incisions or push on the subcutaneously-buried hardware (<xref ref-type="bibr" rid="b126-ndt-4-1111">Servello et al 2008</xref>; <xref ref-type="bibr" rid="b127-ndt-4-1111">Shahed et al 2007</xref>; <xref ref-type="bibr" rid="b129-ndt-4-1111">Sillay et al 2008</xref>). <xref ref-type="bibr" rid="b92-ndt-4-1111">Limousin-Downey and Tisch (2005)</xref> suggest that patients with comorbid OCD symptoms may become obsessed with their DBS systems in terms of thoughts of &#x0201c;mind control&#x0201d;. Moreover, DBS requires ongoing surgical maintenance to replace pulse generators (<xref ref-type="bibr" rid="b23-ndt-4-1111">Bin-Mahfoodh et al 2003</xref>), which last between several months to five years depending upon stimulation parameters, manage hardware-related complications (<xref ref-type="bibr" rid="b110-ndt-4-1111">Oh et al 2002</xref>; <xref ref-type="bibr" rid="b143-ndt-4-1111">Temel et al 2004</xref>; <xref ref-type="bibr" rid="b37-ndt-4-1111">Constantoyannis et al 2005</xref>; <xref ref-type="bibr" rid="b65-ndt-4-1111">Hamani and Lozano 2006</xref>), which have been noted to occur in up to 26% of cases, or adjust the stimulation settings. As has been reported for patients who have received DBS for Parkinson&#x02019;s disease, HFS for TS may induce or exacerbate pre-existing psychiatric symptoms (<xref ref-type="bibr" rid="b8-ndt-4-1111">Appleby et al 2007</xref>).</p></sec></sec><sec><title>Surgical considerations</title><p>With DBS emerging as a promising therapeutic strategy for the management of TS, guidelines have been proposed regarding its use (<xref ref-type="bibr" rid="b101-ndt-4-1111">Mink et al 2006</xref>; <xref ref-type="bibr" rid="b68-ndt-4-1111">Hardesty and Sackeim 2007</xref>; <xref ref-type="bibr" rid="b111-ndt-4-1111">Okun et al 2008</xref>). Since TS symptoms, especially motor symptoms, may dissipate in late adolescence (<xref ref-type="bibr" rid="b89-ndt-4-1111">Leckman et al 1998</xref>), it has been suggested that surgical candidates be at least twenty-five years of age, although <xref ref-type="bibr" rid="b101-ndt-4-1111">Mink and colleagues (2006)</xref> acknowledge that selection of that age is somewhat arbritary. Patient selection should occur in a standardized manner. Patients should have their diagnosis of TS confirmed by two independent clinicians and demonstrate recalcitrance to nonsurgical therapies (<xref ref-type="bibr" rid="b133-ndt-4-1111">Singer et al 2001</xref>; <xref ref-type="bibr" rid="b101-ndt-4-1111">Minks et al 2006</xref>; <xref ref-type="bibr" rid="b150-ndt-4-1111">Visser-Vandewalle 2007</xref>). <xref ref-type="bibr" rid="b150-ndt-4-1111">Visser-Vandewalle (2007)</xref> suggests that this entails a lack of, or at best only partial, response to three different classes of medications (antidopaminergic, anti-psychotic, and experimental agents) and behavioral therapies. Patients should have tics severe enough to significantly impair quality of life and/or pose medical risk, and this is suggested to correspond to a YGTSS total tic severity score of &#x0003e;35/50 for at least one year (which corresponds to tics that are frequent and noticeable in most situations most of the time) (<xref ref-type="bibr" rid="b101-ndt-4-1111">Mink et al 2006</xref>). Patients unsuitable for surgical management include those who have a disorder other than TS, other severe psychiatric co-morbidities, structural cerebral abnormalities, or who have medical contraindications to undergoing surgery (<xref ref-type="bibr" rid="b101-ndt-4-1111">Mink et al 2006</xref>; <xref ref-type="bibr" rid="b150-ndt-4-1111">Visser-Vandewalle 2007</xref>). It is mandatory that an ethics review board oversee DBS clinical trials and that a multidisciplinary team provides ongoing input into clinical trial design and evaluation (<xref ref-type="bibr" rid="b49-ndt-4-1111">Fins 2003</xref>; <xref ref-type="bibr" rid="b109-ndt-4-1111">Nuttin and Gybels 2003</xref>; <xref ref-type="bibr" rid="b57-ndt-4-1111">Gilbert 2006</xref>; <xref ref-type="bibr" rid="b66-ndt-4-1111">Hamani and Moro 2007</xref>). Patients should be assessed using validated and standardized tests (<xref ref-type="bibr" rid="b105-ndt-4-1111">M&#x000fc;ller-Vahl 2002</xref>), such as the YGTSS (<xref ref-type="bibr" rid="b67-ndt-4-1111">Harcherik et al 1984</xref>), RVBRS, Shapiro TS Severity Scale (<xref ref-type="bibr" rid="b128-ndt-4-1111">Shapiro et al 1988</xref>), and TS Symptom List (<xref ref-type="bibr" rid="b88-ndt-4-1111">Leckman et al 1988</xref>), as well as a battery of neuropsychological tests (<xref ref-type="bibr" rid="b101-ndt-4-1111">Mink et al 2006</xref>; <xref ref-type="bibr" rid="b150-ndt-4-1111">Visser-Vandewalle 2007</xref>). Preoperatively, MRI should be performed to facilitate stereotactic planning and post-operatively, imaging is mandatory to confirm electrode placement (<xref ref-type="bibr" rid="b101-ndt-4-1111">Mink et al 2006</xref>). This would additionally provide visualization of the centre of the active contact of stimulation, the positioning of which is crucial to avoid DBS failure (<xref ref-type="bibr" rid="b112-ndt-4-1111">Okun et al 2005</xref>). Since insertion of DBS electrodes can cause a microlesion effect (<xref ref-type="bibr" rid="b71-ndt-4-1111">Houeto et al 2005</xref>), post-operative assessments of DBS efficacy should be performed after these possible effects have resolved and after stimulation parameters have stabilized (<xref ref-type="bibr" rid="b150-ndt-4-1111">Visser-Vandewalle 2007</xref>). Assessment of DBS effects is recommended to be performed in a double-blind fashion. Since DBS for TS remains an experimental therapy, its performance should be limited to neurosurgical centres with DBS experience in the treatment of movement disorders and with collaborations with neurological and psychiatric services (<xref ref-type="bibr" rid="b150-ndt-4-1111">Visser-Vandewalle 2007</xref>; <xref ref-type="bibr" rid="b147-ndt-4-1111">Visser-Vandewalle et al 2006</xref>). As is standard with other therapies, patients must be able to provide informed consent to participate in clinical trials and should be allowed to withdraw from DBS management at any time (<xref ref-type="bibr" rid="b101-ndt-4-1111">Mink et al 2006</xref>; <xref ref-type="bibr" rid="b109-ndt-4-1111">Nuttin and Gybels 2003</xref>). The aim of DBS for TS is solely to relieve patients of their symptoms and not for political, law enforcement, or social purposes (<xref ref-type="bibr" rid="b78-ndt-4-1111">Kopell et al 2004</xref>).</p></sec><sec sec-type="conclusions"><title>Conclusions</title><disp-quote><p>In any scientific treatment which is not fully understood there is the serious danger of not being able to predict possible damage. It should be an inflexible duty to become thoroughly familiar with the drug or procedure to be employed. This implies a thorough understanding of the physiological and psychobiological functions which may have a bearing on the proposed treatment (<xref ref-type="bibr" rid="b43-ndt-4-1111">Diethelm 1939</xref>).</p></disp-quote><p>Oskar <xref ref-type="bibr" rid="b43-ndt-4-1111">Diethelm&#x02019;s (1939)</xref> advice at that 1938 Annual Meeting of the American Psychiatric Association bears relevance even seventy years later. Neurosurgical lesion procedures and DBS have demonstrated therapeutic promise for a subset of patients with TS but have not yet provided sufficient evidence to justify their use as standard therapies for TS. Lesion studies provided the proof-of-principle that TS symptoms could be treated using surgery to target specific cerebral structures, but are limited by methodologic issues in study design, such as their open-label nature (see <xref ref-type="table" rid="t1-ndt-4-1111">Table 1</xref>), unclear patient inclusion and exclusion criteria, and lack of post-operative assessment of the size and location of the lesions performed. To date, most surgical experiences with DBS also have been described in open-label case reports or series with varying degrees of success and with inconsistency in the types of post-operative assessments performed (<xref ref-type="bibr" rid="b144-ndt-4-1111">Temel and Visser-Vandewalle 2004</xref>; <xref ref-type="bibr" rid="b107-ndt-4-1111">Neimat et al 2006</xref>). Ultimately, improvement of the efficacy of surgical strategies for TS will require identification of the patients whose tics are most likely to respond to HFS, performing comprehensive pre-and post-operative blinded and standardized clinical assessments of tic symptoms, and determination of the most appropriate surgical target(s) for resolution of tic symptomatology. It is anticipated that the development of animal models of TS as well as further advances in anatomical and functional imaging technologies will enhance understanding of TS pathophysiology and so lead to the refinement of current surgical strategies (<xref ref-type="bibr" rid="b120-ndt-4-1111">Sachdev and Sachdev 1997</xref>; <xref ref-type="bibr" rid="b121-ndt-4-1111">Sakas et al 2007</xref>).</p></sec></body><back><ack><title>Acknowledgments</title><p>KM acknowledges the generous support of a Killam Scholarship. Work in the Cell Restoration Laboratory is supported by funding from the Stem Cell Network and Atlantic Innovation Fund.</p></ack><fn-group><fn id="fn1-ndt-4-1111"><label>1</label><p>The reported incidence of symptomatic intracerebral hemorrhage associated with stereotactic procedures ranges from 0.6% to 2.1%, with age, male sex, Parkinson&#x02019;s disease, and hypertension found to be significant risk factors (<xref ref-type="bibr" rid="b21-ndt-4-1111">Beric et al 2001</xref>; <xref ref-type="bibr" rid="b47-ndt-4-1111">Favre et al 2002</xref>; <xref ref-type="bibr" rid="b95-ndt-4-1111">Lyons et al 2004</xref>; <xref ref-type="bibr" rid="b22-ndt-4-1111">Binder et al 2005</xref>; <xref ref-type="bibr" rid="b59-ndt-4-1111">Gorgulho et al 2005</xref>; <xref ref-type="bibr" rid="b122-ndt-4-1111">Sansur et al 2007</xref>). It has been found that the incidence of intracerebral hemorrhage following either thalamic DBS or ablative thalamic lesions for parkinsonian tremor is not significantly different (<xref ref-type="bibr" rid="b25-ndt-4-1111">Blomstedt and Hariz 2006</xref>).</p></fn></fn-group><ref-list><title>References</title><ref id="b1-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ackermans</surname><given-names>L</given-names></name><name><surname>Temel</surname><given-names>Y</given-names></name><name><surname>Bauer</surname><given-names>NJC</given-names></name><etal/></person-group><year>2007</year><article-title>Vertical gaze palsy after thalamic stimulation for Tourette syndrome: case report</article-title><source>Neurosurgery</source><volume>61</volume><fpage>E1100</fpage><pub-id pub-id-type="pmid">18091260</pub-id></citation></ref><ref id="b2-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ackermans</surname><given-names>L</given-names></name><name><surname>Temel</surname><given-names>Y</given-names></name><name><surname>Cath</surname><given-names>D</given-names></name><etal/></person-group><year>2006</year><article-title>Deep brain stimulation for Tourette&#x02019;s syndrome: two targets?</article-title><source>Mov Disord</source><volume>21</volume><fpage>709</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">16463374</pub-id></citation></ref><ref id="b3-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albin</surname><given-names>RL</given-names></name><name><surname>Koeppe</surname><given-names>RA</given-names></name><name><surname>Bohnen</surname><given-names>NI</given-names></name><etal/></person-group><year>2003</year><article-title>Increased ventral striatal monoaminergic innervations in Tourette syndrome</article-title><source>Neurology</source><volume>61</volume><fpage>310</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">12913189</pub-id></citation></ref><ref id="b4-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alex</surname><given-names>KD</given-names></name><name><surname>Yavanian</surname><given-names>GJ</given-names></name><name><surname>McFarlane</surname><given-names>HG</given-names></name><etal/></person-group><year>2005</year><article-title>Modulation of dopamine release by striatal 5-HT2C receptors</article-title><source>Synapse</source><volume>55</volume><fpage>242</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">15668911</pub-id></citation></ref><ref id="b5-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>GE</given-names></name><name><surname>DeLong</surname><given-names>MR</given-names></name></person-group><year>1985</year><article-title>Microstimulation of the primate striatum. II. Somatotopic organization of striatal microexcitable zones and their relation to neuronal response properties</article-title><source>J Neurophysiol</source><volume>53</volume><fpage>1417</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">4009227</pub-id></citation></ref><ref id="b6-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anandan</surname><given-names>S</given-names></name><name><surname>Wigg</surname><given-names>CL</given-names></name><name><surname>Thomas</surname><given-names>CR</given-names></name><etal/></person-group><year>2004</year><article-title>Psychosurgery for self-injurious behaviour in Tourette&#x02019;s disorder</article-title><source>J Child Adolesc Psychopharmacol</source><volume>14</volume><fpage>531</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15662144</pub-id></citation></ref><ref id="b7-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>G</given-names></name><name><surname>Pollak</surname><given-names>E</given-names></name><name><surname>Chatterjee</surname><given-names>D</given-names></name><etal/></person-group><year>1992</year><article-title>Postmortem analysis of subcortical monamines and amino acids in Tourette syndrome</article-title><source>Adv Neurol</source><volume>58</volume><fpage>123</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">1414615</pub-id></citation></ref><ref id="b8-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Appleby</surname><given-names>BS</given-names></name><name><surname>Duggan</surname><given-names>PS</given-names></name><name><surname>Regenberg</surname><given-names>A</given-names></name><etal/></person-group><year>2007</year><article-title>Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years&#x02019; experience</article-title><source>Mov Disord</source><volume>22</volume><fpage>1722</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17721929</pub-id></citation></ref><ref id="b9-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Asam</surname><given-names>U</given-names></name><name><surname>Karrass</surname><given-names>W</given-names></name></person-group><year>1981</year><article-title>Gilles de la Tourette syndrome and psychosurgery</article-title><source>Acta Paedopsychiatr</source><volume>47</volume><fpage>39</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">7020328</pub-id></citation></ref><ref id="b10-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Babel</surname><given-names>TB</given-names></name><name><surname>Warnke</surname><given-names>PC</given-names></name><name><surname>Ostertag</surname><given-names>CB</given-names></name></person-group><article-title>Immediate and long term outcome after infrathalamic and thalamic lesioning for intractable Tourette&#x02019;s syndrome</article-title><year>2001</year><source>J Neurol Neurosurg Psychiatry</source><volume>70</volume><fpage>666</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">11309463</pub-id></citation></ref><ref id="b11-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baer</surname><given-names>L</given-names></name><name><surname>Rauch</surname><given-names>SL</given-names></name><name><surname>Jenike</surname><given-names>MA</given-names></name><etal/></person-group><year>1994</year><article-title>Cingulotomy in a case of concomitant obsessive-compulsive disorder and Tourette&#x02019;s syndrome</article-title><source>Arch Gen Psychiatry</source><volume>51</volume><fpage>73</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">8279932</pub-id></citation></ref><ref id="b12-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>EFW</given-names></name></person-group><year>1962</year><article-title>Gilles de la Tourette syndrome treated by bimedial frontal leucotomy</article-title><source>Can Med Assoc J</source><volume>86</volume><fpage>746</fpage><lpage>7</lpage></citation></ref><ref id="b13-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ballantine</surname><given-names>HT</given-names></name><name><surname>Boukoms</surname><given-names>AJ</given-names></name><name><surname>Thomas</surname><given-names>EK</given-names></name><etal/></person-group><year>1987</year><article-title>Treatment of psychiatric illness by stereotactic cingulotomy</article-title><source>Biol Psychiatry</source><volume>22</volume><fpage>807</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">3300791</pub-id></citation></ref><ref id="b14-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balthasar</surname><given-names>K</given-names></name></person-group><year>1957</year><article-title>&#x000dc;ber das anatomische Substrat de generalisierten Tic-Krankheit (maladie des tics, Gilles de la Tourette): Entwicklungshemmung des corpus striatum</article-title><source>Archiv f&#x000fc;r Psychiatrie und Nervenkrankheiten</source><volume>195</volume><fpage>531</fpage><lpage>49</lpage></citation></ref><ref id="b15-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baym</surname><given-names>CL</given-names></name><name><surname>Corbett</surname><given-names>BA</given-names></name><name><surname>Wright</surname><given-names>SB</given-names></name><etal/></person-group><year>2008</year><article-title>Neural correlates of tic severity and cognitive control in children with Tourette syndrome</article-title><source>Brain</source><volume>131</volume><fpage>165</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">18056159</pub-id></citation></ref><ref id="b16-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beard</surname><given-names>GM</given-names></name></person-group><year>1880&#x02013;1881</year><article-title>Experiments with the &#x02018;jumpers&#x02019; or &#x02018;jumping Frenchmen&#x02019; of Maine</article-title><source>Pop Sci Month (NY)</source><volume>18</volume><fpage>170</fpage></citation></ref><ref id="b17-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beckers</surname><given-names>W</given-names></name></person-group><year>1973</year><article-title>Gilles de la Tourette&#x02019;s disease based on five own observations</article-title><source>Arch Psychiatr Nervenkr</source><volume>217</volume><fpage>169</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">4145826</pub-id></citation></ref><ref id="b18-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benabid</surname><given-names>AL</given-names></name><name><surname>Pollak</surname><given-names>P</given-names></name><name><surname>Louveau</surname><given-names>A</given-names></name><etal/></person-group><year>1987</year><article-title>Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease</article-title><source>Appl Neurophysiol</source><volume>50</volume><fpage>344</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">3329873</pub-id></citation></ref><ref id="b19-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benabid</surname><given-names>AL</given-names></name></person-group><year>2007</year><article-title>What the future holds for deep brain stimulation</article-title><source>Expert Rev Med Devices</source><volume>4</volume><fpage>895</fpage><lpage>903</lpage><pub-id pub-id-type="pmid">18035954</pub-id></citation></ref><ref id="b20-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benazzouz</surname><given-names>A</given-names></name><name><surname>Hallet</surname><given-names>M</given-names></name></person-group><year>2000</year><article-title>Mechanism of action of deep brain stimulation</article-title><source>Neurology</source><volume>55</volume><issue>Suppl 6</issue><fpage>S13</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">11188968</pub-id></citation></ref><ref id="b21-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beric</surname><given-names>A</given-names></name><name><surname>Kelly</surname><given-names>PJ</given-names></name><name><surname>Rezai</surname><given-names>A</given-names></name><etal/></person-group><year>2001</year><article-title>Complications of deep brain stimulation surgery</article-title><source>Stereotact Funct Neurosurg</source><volume>77</volume><fpage>73</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12378060</pub-id></citation></ref><ref id="b22-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Binder</surname><given-names>DK</given-names></name><name><surname>Rau</surname><given-names>GM</given-names></name><name><surname>Starr</surname><given-names>PA</given-names></name></person-group><year>2005</year><article-title>Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders</article-title><source>Neurosurgery</source><volume>56</volume><fpage>722</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">15792511</pub-id></citation></ref><ref id="b23-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bin-Mahfoodh</surname><given-names>M</given-names></name><name><surname>Hamani</surname><given-names>C</given-names></name><name><surname>Sime</surname><given-names>E</given-names></name><etal/></person-group><year>2003</year><article-title>Longevity of batteries in internal pulse generators used for deep brain stimulation</article-title><source>Stereotact Funct Neurosurg</source><volume>80</volume><fpage>56</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">14745210</pub-id></citation></ref><ref id="b24-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bloch</surname><given-names>MH</given-names></name><name><surname>Leckman</surname><given-names>JF</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><etal/></person-group><year>2005</year><article-title>Caudate volumes in childhood predict symptom severity in adults of Tourette syndrome</article-title><source>Neurology</source><volume>65</volume><fpage>1253</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16247053</pub-id></citation></ref><ref id="b25-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blomstedt</surname><given-names>P</given-names></name><name><surname>Hariz</surname><given-names>MI</given-names></name></person-group><year>2006</year><article-title>Are complications less common in deep brain stimulation than in ablative procedures for movement disorders?</article-title><source>Stereotact Funct Neurosurg</source><volume>84</volume><fpage>72</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">16790989</pub-id></citation></ref><ref id="b26-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bohlhalter</surname><given-names>S</given-names></name><name><surname>Goldfine</surname><given-names>A</given-names></name><name><surname>Matteson</surname><given-names>S</given-names></name><etal/></person-group><year>2006</year><article-title>Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study</article-title><source>Brain</source><volume>129</volume><fpage>2029</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">16520330</pub-id></citation></ref><ref id="b27-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bruun</surname><given-names>RD</given-names></name><name><surname>Budman</surname><given-names>CL</given-names></name></person-group><year>1992</year><article-title>The natural history of Tourette syndrome</article-title><source>Adv Neurol</source><volume>58</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">1414612</pub-id></citation></ref><ref id="b28-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>IJ</given-names></name><name><surname>Koslow</surname><given-names>SH</given-names></name><name><surname>Seifert</surname><given-names>WE</given-names><suffix>Jr</suffix></name><etal/></person-group><year>1979</year><article-title>Biogenic amine metabolism in Tourette syndrome</article-title><source>Ann Neurol</source><volume>27</volume><fpage>443</fpage><lpage>6</lpage></citation></ref><ref id="b29-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>KM</given-names></name><name><surname>Veldman</surname><given-names>MB</given-names></name><name><surname>McGrath</surname><given-names>MJ</given-names></name><etal/></person-group><year>2000</year><article-title>TS+OCD-like neuropotentiated mice are supersensitive to seizure induction</article-title><source>Neuro-report</source><volume>11</volume><fpage>2335</fpage><lpage>8</lpage></citation></ref><ref id="b30-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cappabianca</surname><given-names>P</given-names></name><name><surname>Spaziante</surname><given-names>R</given-names></name><name><surname>Carrabs</surname><given-names>G</given-names></name><etal/></person-group><year>1987</year><article-title>Surgical stereotactic treatment for Gilles de la Tourette&#x02019;s syndrome</article-title><source>Acta Neurol (Napoli)</source><volume>9</volume><fpage>273</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">3324652</pub-id></citation></ref><ref id="b31-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carta</surname><given-names>M</given-names></name><name><surname>Carlsson</surname><given-names>T</given-names></name><name><surname>Kirik</surname><given-names>D</given-names></name><etal/></person-group><year>2007</year><article-title>Dopamine released from 5-HT terminal is the cause of L-DOPA-induced dyskinesias in parkinsonian rats</article-title><source>Brain</source><volume>130</volume><fpage>1819</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">17452372</pub-id></citation></ref><ref id="b32-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castellanos</surname><given-names>FX</given-names></name><name><surname>Fine</surname><given-names>EJ</given-names></name><name><surname>Kaysen</surname><given-names>DL</given-names></name><etal/></person-group><year>1996</year><article-title>Sensorimotor gating in boys with Tourette&#x02019;s Syndrome and ADHD: preliminary results</article-title><source>Biol Psychiatry</source><volume>39</volume><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">8719124</pub-id></citation></ref><ref id="b33-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>J-Y</given-names></name><name><surname>Shi</surname><given-names>L-H</given-names></name><name><surname>Luo</surname><given-names>F</given-names></name><etal/></person-group><year>2008</year><article-title>Studies of the neural mechanisms of deep brain stimulation in rodent models of Parkinson&#x02019;s disease</article-title><source>Neurosci Biobehav Rev</source><volume>32</volume><fpage>352</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">18035416</pub-id></citation></ref><ref id="b34-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheon</surname><given-names>KA</given-names></name><name><surname>Ryu</surname><given-names>YH</given-names></name><name><surname>Namkoong</surname><given-names>K</given-names></name><etal/></person-group><year>2004</year><article-title>Dopamine transporter density of the basal ganglia assessed with [123I]IPT-SPECT in drug-naive children with Tourette&#x02019;s disorder</article-title><source>Psychiatry Res</source><volume>130</volume><fpage>85</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">14972371</pub-id></citation></ref><ref id="b35-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Comings</surname><given-names>DE</given-names></name></person-group><year>1990</year><article-title>Blood serotonin and tryptophan in Tourette syndrome</article-title><source>Am J Med Genet</source><volume>36</volume><fpage>418</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">2389798</pub-id></citation></ref><ref id="b36-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Como</surname><given-names>P</given-names></name></person-group><year>1995</year><article-title>Obsessive-compulsive disorder in Tourette&#x02019;s syndrome</article-title><source>Adv Neurol</source><volume>65</volume><fpage>281</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">7872146</pub-id></citation></ref><ref id="b37-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Constantoyannis</surname><given-names>C</given-names></name><name><surname>Berk</surname><given-names>C</given-names></name><name><surname>Honey</surname><given-names>CR</given-names></name><etal/></person-group><year>2005</year><article-title>Reducing hardware-related complications of deep brain stimulation</article-title><source>Can J Neurol Sci</source><volume>32</volume><fpage>194</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">16018154</pub-id></citation></ref><ref id="b38-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Divitiis</surname><given-names>E</given-names></name><name><surname>D&#x02019;Errico</surname><given-names>A</given-names></name><name><surname>Cerillo</surname><given-names>A</given-names></name></person-group><year>1977</year><article-title>Stereotactic surgery in Gilles de la Tourette syndrome</article-title><source>Acta Neurochir (Wien), Suppl</source><volume>24</volume><fpage>73</fpage></citation></ref><ref id="b39-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Demirkiran</surname><given-names>M</given-names></name><name><surname>Jankovic</surname><given-names>J</given-names></name></person-group><year>1995</year><article-title>Paroxysmal dyskinesias: clinical features and classification</article-title><source>Ann Neurol</source><volume>38</volume><fpage>571</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7574453</pub-id></citation></ref><ref id="b40-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Denkla</surname><given-names>BM</given-names></name><name><surname>Harris</surname><given-names>EL</given-names></name><name><surname>Aylward</surname><given-names>EH</given-names></name><etal/></person-group><year>1991</year><article-title>Executive function and volume of the basal ganglia in children in with Tourette syndrome and attention deficit hyperactivity disorder</article-title><source>Ann Neurol</source><volume>30</volume><fpage>476</fpage></citation></ref><ref id="b41-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeWulf</surname><given-names>A</given-names></name><name><surname>van Bogaert</surname><given-names>L</given-names></name></person-group><year>1941</year><article-title>Etudes anatomo-cliniques des syndromes hypercin&#x000e9;tiques complexes, III. Une observation anatomo-clinique de maladie des tics (Gilles de la Tourette)</article-title><source>Monatsschrift f&#x000fc;r Psychiatrie und Neurologie</source><volume>104</volume><fpage>53</fpage><lpage>61</lpage></citation></ref><ref id="b42-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diederich</surname><given-names>NJ</given-names></name><name><surname>Kalteis</surname><given-names>K</given-names></name><name><surname>Stamenkovic</surname><given-names>M</given-names></name><etal/></person-group><year>2005</year><article-title>Efficient internal pallidal stimulation in Gilles de la Tourette Syndrome: a case report</article-title><source>Mov Disord</source><volume>20</volume><fpage>1496</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">16037913</pub-id></citation></ref><ref id="b43-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diethelm</surname><given-names>O</given-names></name></person-group><year>1939</year><article-title>An historical review of somatic therapy in psychiatry</article-title><source>Am J Psychiatry</source><volume>95</volume><fpage>1165</fpage><lpage>79</lpage></citation></ref><ref id="b44-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dostrovsky</surname><given-names>JO</given-names></name><name><surname>Lozano</surname><given-names>AM</given-names></name></person-group><year>2002</year><article-title>Mechanisms of deep brain stimulation</article-title><source>Mov Disord</source><volume>17</volume><issue>Suppl 1</issue><fpage>S63</fpage><lpage>S68</lpage><pub-id pub-id-type="pmid">11948756</pub-id></citation></ref><ref id="b45-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eidelberg</surname><given-names>D</given-names></name><name><surname>Moeller</surname><given-names>JR</given-names></name><name><surname>Antonini</surname><given-names>A</given-names></name><etal/></person-group><year>1997</year><article-title>The metabolic anatomy of Tourette&#x02019;s syndrome</article-title><source>Neurology</source><volume>48</volume><fpage>927</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">9109879</pub-id></citation></ref><ref id="b46-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname><given-names>M</given-names></name><name><surname>Zametkin</surname><given-names>AJ</given-names></name><name><surname>Jons</surname><given-names>PH</given-names></name><etal/></person-group><year>1999</year><article-title>High presynaptic dopaminergic activity in children with Tourette&#x02019;s disorder</article-title><source>J Am Acad Child Adolesc Psychiatry</source><volume>38</volume><fpage>86</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">9893421</pub-id></citation></ref><ref id="b47-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Favre</surname><given-names>J</given-names></name><name><surname>Taha</surname><given-names>JM</given-names></name><name><surname>Burchiel</surname><given-names>KJ</given-names></name></person-group><year>2002</year><article-title>An analysis of the respective risks of hematoma formation in 361 consecutive morphological and functional stereotactic procedures</article-title><source>Neurosurgery</source><volume>50</volume><fpage>48</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">11844234</pub-id></citation></ref><ref id="b48-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Filali</surname><given-names>M</given-names></name><name><surname>Hutchison</surname><given-names>WD</given-names></name><name><surname>Palter</surname><given-names>VN</given-names></name><etal/></person-group><year>2004</year><article-title>Stimulation-induced inhibition of neuronal firing in human subthalamic nucleus</article-title><source>Exp Brain Res</source><volume>156</volume><fpage>274</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">14745464</pub-id></citation></ref><ref id="b49-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fins</surname><given-names>JJ</given-names></name></person-group><year>2003</year><article-title>From psychosurgery to neuromodulation and palliation: history&#x02019;s lessons for the ethical conduct and regulation of neuropsychiatric research</article-title><source>Neurosurg Clin N Am</source><volume>14</volume><fpage>303</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">12856496</pub-id></citation></ref><ref id="b50-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flaherty</surname><given-names>AW</given-names></name><name><surname>Williams</surname><given-names>ZM</given-names></name><name><surname>Amirnovin</surname><given-names>R</given-names></name><etal/></person-group><year>2005</year><article-title>Deep brain stimulation of the anterior internal capsule for the treatment of Tourette syndrome: technical case report</article-title><source>Neurosurgery</source><volume>ONS4</volume><fpage>E403</fpage><pub-id pub-id-type="pmid">16234657</pub-id></citation></ref><ref id="b51-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frankel</surname><given-names>M</given-names></name><name><surname>Cummings</surname><given-names>J</given-names></name><name><surname>Robertson</surname><given-names>M</given-names></name><etal/></person-group><year>1986</year><article-title>Obsessions and compulsions in Gilles de la Tourette&#x02019;s syndrome</article-title><source>Adv Neurol</source><volume>36</volume><fpage>378</fpage><lpage>82</lpage></citation></ref><ref id="b52-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freudenberg</surname><given-names>F</given-names></name><name><surname>Dieckmann</surname><given-names>M</given-names></name><name><surname>Winter</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>Selective breeding for deficient sensorimotor gating is accompanied by increased perseveration in rats</article-title><source>Neuroscience</source><volume>148</volume><fpage>612</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">17693035</pub-id></citation></ref><ref id="b53-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>KA</given-names></name><name><surname>Albin</surname><given-names>RL</given-names></name></person-group><article-title>Neuroimaging of Tourette syndrome</article-title><year>2006</year><source>J Child Neurol</source><volume>21</volume><fpage>672</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16970868</pub-id></citation></ref><ref id="b54-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fukada</surname><given-names>M</given-names></name><name><surname>Mentis</surname><given-names>MJ</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><etal/></person-group><year>2001</year><article-title>Networks mediating the clinical effects of pallidal brain stimulation for Parkinson&#x02019;s disease: a PET study of resting-state glucose metabolism</article-title><source>Brain</source><volume>124</volume><fpage>1601</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11459751</pub-id></citation></ref><ref id="b55-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gallagher</surname><given-names>CL</given-names></name><name><surname>Garell</surname><given-names>PC</given-names></name><name><surname>Montgomery</surname><given-names>EB</given-names><suffix>Jr</suffix></name></person-group><year>2006</year><article-title>Hemi tics and deep brain stimulation</article-title><source>Neurology</source><volume>66</volume><fpage>E12</fpage><pub-id pub-id-type="pmid">16476922</pub-id></citation></ref><ref id="b56-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>L</given-names></name><name><surname>D&#x02019;Alessandro</surname><given-names>G</given-names></name><name><surname>Bioulac</surname><given-names>B</given-names></name><etal/></person-group><year>2005</year><article-title>High-frequency stimulation in Parkinson&#x02019;s disease: more or less?</article-title><source>Trends Neurosci</source><volume>22</volume><fpage>209</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">15808356</pub-id></citation></ref><ref id="b57-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>D</given-names></name></person-group><year>2006</year><article-title>Treatment of children and adolescents with tics and tourette syndrome</article-title><source>J Child Neurol</source><volume>21</volume><fpage>690</fpage><lpage>700</lpage><pub-id pub-id-type="pmid">16970870</pub-id></citation></ref><ref id="b58-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilles de la Tourette</surname><given-names>GAEB</given-names></name></person-group><year>1885</year><article-title>Etude sur une affection nerveuse caracterisee par de l&#x02019;incoordination motrice accompagnee d&#x02019;echolalie et de copralalie</article-title><source>Arch Neurol</source><volume>9</volume><fpage>19</fpage><lpage>42</lpage></citation></ref><ref id="b59-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gorgulho</surname><given-names>A</given-names></name><name><surname>De Salles</surname><given-names>AA</given-names></name><name><surname>Frighetto</surname><given-names>L</given-names></name><etal/></person-group><year>2005</year><article-title>Incidence of hemorrhage associated with electrophysiological studies performed using macroelectrodes and microelectrodes in functional neurosurgery</article-title><source>J Neurosurg</source><volume>105</volume><fpage>888</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">15926715</pub-id></citation></ref><ref id="b60-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grabli</surname><given-names>D</given-names></name><name><surname>McCairn</surname><given-names>K</given-names></name><name><surname>Hirsch</surname><given-names>EC</given-names></name><etal/></person-group><year>2004</year><article-title>Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study</article-title><source>Brain</source><volume>127</volume><fpage>2039</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">15292053</pub-id></citation></ref><ref id="b61-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Graybiel</surname><given-names>AM</given-names></name><name><surname>Aosaki</surname><given-names>T</given-names></name><name><surname>Flaherty</surname><given-names>AW</given-names></name><etal/></person-group><year>1994</year><article-title>The basal ganglia and adaptive motor control</article-title><source>Science</source><volume>265</volume><fpage>1826</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">8091209</pub-id></citation></ref><ref id="b62-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haber</surname><given-names>S</given-names></name><name><surname>Kowall</surname><given-names>N</given-names></name><name><surname>Vonsattel</surname><given-names>J</given-names></name><etal/></person-group><year>1986</year><article-title>Gilles de la Tourette syndrome: a post-mortem neuropathological and immunohistochemical study</article-title><source>J Neurol Sci</source><volume>75</volume><fpage>225</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">2428943</pub-id></citation></ref><ref id="b63-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haber</surname><given-names>SN</given-names></name><name><surname>Wolfer</surname><given-names>D</given-names></name></person-group><year>1992</year><article-title>Basal ganglia peptidergic staining in Tourette syndrome: a follow-up study</article-title><source>Adv Neurol</source><volume>48</volume><fpage>145</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">1414617</pub-id></citation></ref><ref id="b64-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hadamitzky</surname><given-names>M</given-names></name><name><surname>Harich</surname><given-names>S</given-names></name><name><surname>Koch</surname><given-names>M</given-names></name><etal/></person-group><year>2007</year><article-title>Deficient pre-pulse inhibition induced by selective breeding of rats can be restored by the dopamine D2 antagonist haloperidol</article-title><source>Behav Brain Res</source><volume>177</volume><fpage>364</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17182114</pub-id></citation></ref><ref id="b65-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamani</surname><given-names>C</given-names></name><name><surname>Lozano</surname><given-names>AM</given-names></name></person-group><year>2006</year><article-title>Hardware-related complications of deep brain stimulation: a review of the published literature</article-title><source>Stereotact Func Neurosurg</source><volume>84</volume><fpage>248</fpage><lpage>51</lpage></citation></ref><ref id="b66-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamani</surname><given-names>C</given-names></name><name><surname>Moro</surname><given-names>E</given-names></name></person-group><year>2007</year><article-title>Surgery for other movement disorders: dystonia, tics</article-title><source>Curr Opin Neurol</source><volume>20</volume><fpage>470</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17620884</pub-id></citation></ref><ref id="b67-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harcherik</surname><given-names>DF</given-names></name><name><surname>Leckman</surname><given-names>JF</given-names></name><name><surname>Detlor</surname><given-names>J</given-names></name><etal/></person-group><year>1984</year><article-title>A new instrument for clinical studies of Tourette&#x02019;s syndrome</article-title><source>Am J Acad Child Psychiatry</source><volume>23</volume><fpage>153</fpage><lpage>60</lpage></citation></ref><ref id="b68-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hardesty</surname><given-names>DE</given-names></name><name><surname>Sackeim</surname><given-names>HA</given-names></name></person-group><year>2007</year><article-title>Deep brain stimulation in movement and psychiatric disorders</article-title><source>Biol Psychiatry</source><volume>61</volume><fpage>831</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17126303</pub-id></citation></ref><ref id="b69-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>K</given-names></name><name><surname>Singer</surname><given-names>HS</given-names></name></person-group><year>2006</year><article-title>Tic disorders: neural circuits, neurochemistry, and neuroimmunology</article-title><source>J Child Neurol</source><volume>21</volume><fpage>678</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">16970869</pub-id></citation></ref><ref id="b70-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hassler</surname><given-names>R</given-names></name><name><surname>Dieckmann</surname><given-names>G</given-names></name></person-group><year>1970</year><article-title>Traitement st&#x000e9;r&#x000e9;otaxique des tics et cris inarticul&#x000e9;s ou coprolaliques consid&#x000e9;r&#x000e9;s comme phenomena d&#x02019;obsession motrice au cours de la maladie de Gilles de la Tourette</article-title><source>Revue Neurologique (Paris)</source><volume>123</volume><fpage>89</fpage><lpage>100</lpage></citation></ref><ref id="b71-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Houeto</surname><given-names>JL</given-names></name><name><surname>Karachi</surname><given-names>C</given-names></name><name><surname>Mallet</surname><given-names>L</given-names></name><etal/></person-group><year>2005</year><article-title>Tourette&#x02019;s syndrome and deep brain stimulation</article-title><source>J Neurol Neurosurg Psychiatry</source><volume>76</volume><fpage>992</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15965209</pub-id></citation></ref><ref id="b72-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hyde</surname><given-names>TM</given-names></name><name><surname>Stacey</surname><given-names>ME</given-names></name><name><surname>Coppola</surname><given-names>R</given-names></name><etal/></person-group><year>1995</year><article-title>Cerebral morphometric abnormalities in Tourette&#x02019;s syndrome: a quantitative MRI study of monozygotic twins</article-title><source>Neurology</source><volume>45</volume><fpage>1176</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">7783885</pub-id></citation></ref><ref id="b73-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Itard</surname><given-names>JMG</given-names></name></person-group><year>1825</year><article-title>M&#x000e9;moire sure quelques fonctions involontaires des appareils de la locomotion, de la pr&#x000e9;hension et de la voix</article-title><source>Archives Generales de M&#x000e9;decine</source><volume>8</volume><fpage>385</fpage><lpage>407</lpage></citation></ref><ref id="b74-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jankovic</surname><given-names>J</given-names></name></person-group><year>1994</year><article-title>Botulinum toxin in the treatment of dystonic tics</article-title><source>Mov Disord</source><volume>9</volume><fpage>347</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8041378</pub-id></citation></ref><ref id="b75-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jankovic</surname><given-names>J</given-names></name></person-group><year>2001</year><article-title>Tourette&#x02019;s syndrome</article-title><source>N Engl J Med</source><volume>345</volume><fpage>1184</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">11642235</pub-id></citation></ref><ref id="b76-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jim&#x000e9;nez-Jim&#x000e9;nez</surname><given-names>FJ</given-names></name><name><surname>Garc&#x000ed;a-Ruiz</surname><given-names>PJ</given-names></name></person-group><year>2001</year><article-title>Pharmacological options for the treatment of Tourette&#x02019;s disorder</article-title><source>Drugs</source><volume>61</volume><fpage>2207</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">11772131</pub-id></citation></ref><ref id="b77-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalanithi</surname><given-names>PSA</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><name><surname>Kataoka</surname><given-names>Y</given-names></name><etal/></person-group><year>2005</year><article-title>Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome</article-title><source>Proc Natl Acad Sci U S A</source><volume>102</volume><fpage>13307</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">16131542</pub-id></citation></ref><ref id="b78-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kopell</surname><given-names>BH</given-names></name><name><surname>Greenberg</surname><given-names>B</given-names></name><name><surname>Rezai</surname><given-names>AR</given-names></name></person-group><year>2004</year><article-title>Deep brain stimulation for psychiatric disorders</article-title><source>J Clin Neurophysiol</source><volume>21</volume><fpage>51</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">15097294</pub-id></citation></ref><ref id="b79-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kopell</surname><given-names>BH</given-names></name><name><surname>Rezai</surname><given-names>AR</given-names></name></person-group><year>2003</year><article-title>Psychiatric neurosurgery: a historical perspective</article-title><source>Neurosurg Clin N Am</source><volume>14</volume><fpage>181</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">12856487</pub-id></citation></ref><ref id="b80-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krauss</surname><given-names>JK</given-names></name><name><surname>Jankovic</surname><given-names>J</given-names></name></person-group><article-title>Severe motor tics causing cervical myelopathy in Tourette&#x02019;s syndrome</article-title><source>Mov Disord</source><volume>11</volume><fpage>563</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8866498</pub-id></citation></ref><ref id="b81-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>J</given-names></name><name><surname>Lenartz</surname><given-names>D</given-names></name><name><surname>Mai</surname><given-names>JK</given-names></name><etal/></person-group><year>2007</year><article-title>Deep brain stimulation of the nucleus accumbens and the internal capsule in therapeutically refractory Tourette-syndrome</article-title><source>J Neurol</source><volume>254</volume><fpage>963</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17410328</pub-id></citation></ref><ref id="b82-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kulisevsky</surname><given-names>J</given-names></name><name><surname>Berthier</surname><given-names>ML</given-names></name><name><surname>Avila</surname><given-names>A</given-names></name></person-group><year>1995</year><article-title>Longitudinal evolution of prefrontal leucotomy in Tourette&#x02019;s syndrome</article-title><source>Movement Disorders</source><volume>10</volume><fpage>345</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">7651455</pub-id></citation></ref><ref id="b83-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kurlan</surname><given-names>R</given-names></name></person-group><year>1997</year><article-title>Treatment of tics</article-title><source>Neurol Clin</source><volume>15</volume><fpage>403</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9115470</pub-id></citation></ref><ref id="b84-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kurlan</surname><given-names>R</given-names></name><name><surname>Caine</surname><given-names>E</given-names></name><name><surname>Lichter</surname><given-names>D</given-names></name><etal/></person-group><year>1988</year><article-title>Surgical treatment of severe obsessive-compulsive disorder associated with Tourette&#x02019;s syndrome</article-title><source>Neurology</source><volume>38</volume><issue>Suppl 1</issue><fpage>203</fpage><lpage>4</lpage></citation></ref><ref id="b85-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kurlan</surname><given-names>R</given-names></name><name><surname>Kersun</surname><given-names>J</given-names></name><name><surname>Ballantine</surname><given-names>HT</given-names><suffix>Jr</suffix></name><etal/></person-group><year>1990</year><article-title>Neurosurgical treatment of severe obsessive-compulsive disorder associated with Tourette&#x02019;s syndrome</article-title><source>Mov Disord</source><volume>5</volume><fpage>152</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">2325677</pub-id></citation></ref><ref id="b86-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lavenstein</surname><given-names>BL</given-names></name></person-group><year>2003</year><article-title>Treatment approaches for children with Tourette&#x02019;s syndrome</article-title><source>Curr Neurol Neurosci Rep</source><volume>3</volume><fpage>143</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12583843</pub-id></citation></ref><ref id="b87-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leckman</surname><given-names>JF</given-names></name><name><surname>de Lotbini&#x000e8;re</surname><given-names>AJ</given-names></name><name><surname>Marek</surname><given-names>K</given-names></name><etal/></person-group><year>1993</year><article-title>Severe disturbances in speech, swallowing, and gait following stereotactic infrathalamic lesions in Gilles de la Tourette&#x02019;s syndrome</article-title><source>Neurology</source><volume>43</volume><fpage>890</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">8492943</pub-id></citation></ref><ref id="b88-ndt-4-1111"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Leckman</surname><given-names>JF</given-names></name><name><surname>Towbin</surname><given-names>KE</given-names></name><name><surname>Ort</surname><given-names>SI</given-names></name><etal/></person-group><person-group person-group-type="editor"><name><surname>Cohen</surname><given-names>DJ</given-names></name><name><surname>Bruun</surname><given-names>RD</given-names></name><name><surname>Leckman</surname><given-names>JF</given-names></name></person-group><year>1988</year><article-title>Clinical assessment of tic disorder severity</article-title><source>Tourette&#x02019;s Syndrome and Tic Disorders</source><publisher-loc>New York</publisher-loc><publisher-name>Wiley</publisher-name><fpage>55</fpage><lpage>78</lpage></citation></ref><ref id="b89-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leckman</surname><given-names>JF</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Vitale</surname><given-names>A</given-names></name><etal/></person-group><year>1998</year><article-title>Course of tic severity in Tourette syndrome: the first two decades</article-title><source>Pediatrics</source><volume>102</volume><fpage>14</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9651407</pub-id></citation></ref><ref id="b90-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leckman</surname><given-names>JF</given-names></name></person-group><year>2002</year><article-title>Tourette&#x02019;s syndrome</article-title><source>Lancet</source><volume>360</volume><fpage>577</fpage><lpage>86</lpage></citation></ref><ref id="b91-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lerner</surname><given-names>A</given-names></name><name><surname>Bagic</surname><given-names>A</given-names></name><name><surname>Boudreau</surname><given-names>FA</given-names></name><etal/></person-group><year>2007</year><article-title>Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome</article-title><source>Neurology</source><volume>68</volume><fpage>1979</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">17548547</pub-id></citation></ref><ref id="b92-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Limousin-Dowsey</surname><given-names>P</given-names></name><name><surname>Tisch</surname><given-names>S</given-names></name></person-group><year>2005</year><article-title>Surgery for movement disorders: new applications?</article-title><source>J Neurol Neurosurg Psychiatry</source><volume>76</volume><fpage>904</fpage><pub-id pub-id-type="pmid">15965193</pub-id></citation></ref><ref id="b93-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Postupna</surname><given-names>N</given-names></name><name><surname>Falkenberg</surname><given-names>J</given-names></name><etal/></person-group><year>2008</year><article-title>High frequency deep brain stimulation: what are the therapeutic mechanisms?</article-title><source>Neurosci Biobehav Rev</source><volume>32</volume><fpage>343</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">17187859</pub-id></citation></ref><ref id="b94-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lozano</surname><given-names>AM</given-names></name><name><surname>Mahat</surname><given-names>N</given-names></name></person-group><year>2004</year><article-title>Deep brain stimulation surgery for Parkinson&#x02019;s disease: mechanisms and consequences</article-title><source>Parkinsonism Relat Disord</source><volume>10</volume><fpage>S49</fpage><lpage>S57</lpage><pub-id pub-id-type="pmid">15109587</pub-id></citation></ref><ref id="b95-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>KE</given-names></name><name><surname>Wilkinson</surname><given-names>SB</given-names></name><name><surname>Overman</surname><given-names>J</given-names></name><etal/></person-group><year>2004</year><article-title>Surgical and hardware complications of subthalamic stimulation: a series of 160 procedures</article-title><source>Neurology</source><volume>63</volume><fpage>612</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15326230</pub-id></citation></ref><ref id="b96-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maciunas</surname><given-names>RJ</given-names></name><name><surname>Maddux</surname><given-names>BN</given-names></name><name><surname>Riley</surname><given-names>DE</given-names></name><etal/></person-group><year>2007</year><article-title>Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome</article-title><source>J Neurosurg</source><volume>107</volume><fpage>1004</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">17977274</pub-id></citation></ref><ref id="b97-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mahler</surname><given-names>M</given-names></name><name><surname>Luke</surname><given-names>J</given-names></name></person-group><article-title>Outcome of the tic syndrome</article-title><source>J Nerv Ment Dis</source><volume>103</volume><fpage>433</fpage><lpage>45</lpage></citation></ref><ref id="b98-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McGrath</surname><given-names>MJ</given-names></name><name><surname>Campbell</surname><given-names>KM</given-names></name><name><surname>Parks</surname><given-names>CR</given-names></name><etal/></person-group><year>2000</year><article-title>Glutamatergic drugs exacerbate symptomatic behaviour in a transgenic model of comorbid Tourette&#x02019;s syndrome and obsessive-compulsive disorder</article-title><source>Brain Res</source><volume>877</volume><fpage>23</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">10980239</pub-id></citation></ref><ref id="b99-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McIntyre</surname><given-names>CC</given-names></name><name><surname>Savasta</surname><given-names>M</given-names></name><name><surname>Walter</surname><given-names>BJ</given-names></name><etal/></person-group><year>2004</year><article-title>How does deep brain stimulation work? Present understanding and future questions</article-title><source>J Clin Neurophysiol</source><volume>21</volume><fpage>40</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">15097293</pub-id></citation></ref><ref id="b100-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mink</surname><given-names>JW</given-names></name></person-group><year>2001</year><article-title>Basal ganglia dysfunction in Tourette&#x02019;s syndrome: a new hypothesis</article-title><source>Pediatr Neurol</source><volume>25</volume><fpage>190</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11587872</pub-id></citation></ref><ref id="b101-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mink</surname><given-names>JW</given-names></name><name><surname>Walkup</surname><given-names>J</given-names></name><name><surname>Frey</surname><given-names>KA</given-names></name><etal/></person-group><year>2006</year><article-title>Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome</article-title><source>Mov Disord</source><volume>21</volume><fpage>1831</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16991144</pub-id></citation></ref><ref id="b102-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moldofsky</surname><given-names>H</given-names></name><name><surname>Tullis</surname><given-names>C</given-names></name><name><surname>Lamon</surname><given-names>R</given-names></name></person-group><year>1974</year><article-title>Multiple tic syndrome (Gilles de la Tourette&#x02019;s syndrome)</article-title><source>J Nerv Ment Dis</source><volume>159</volume><fpage>282</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">4529247</pub-id></citation></ref><ref id="b103-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Montgomery</surname><given-names>EB</given-names><suffix>Jr</suffix></name><name><surname>Gale</surname><given-names>JT</given-names></name></person-group><year>2008</year><article-title>Mechanisms of action of deep brain stimulation</article-title><source>Neurosci Biobehav Rev</source><volume>32</volume><fpage>388</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">17706780</pub-id></citation></ref><ref id="b104-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moriarty</surname><given-names>J</given-names></name><name><surname>Varma</surname><given-names>AR</given-names></name><name><surname>Stevens</surname><given-names>J</given-names></name><etal/></person-group><year>1997</year><article-title>A volumetric MRI study of Gilles de la Tourette&#x02019;s syndrome</article-title><source>Neurology</source><volume>49</volume><fpage>410</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">9270569</pub-id></citation></ref><ref id="b105-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;ller-Vahl</surname><given-names>KR</given-names></name></person-group><year>2002</year><article-title>The treatment of Tourette&#x02019;s syndrome: current opinions</article-title><source>Expert Opin Pharmacother</source><volume>3</volume><fpage>899</fpage><lpage>914</lpage><pub-id pub-id-type="pmid">12083990</pub-id></citation></ref><ref id="b106-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>N&#x000e1;dvorn&#x000ed;k</surname><given-names>P</given-names></name><name><surname>&#x00160;ramka</surname><given-names>M</given-names></name><name><surname>Lis&#x000fd;</surname><given-names>L</given-names></name><etal/></person-group><year>1972</year><article-title>Experiences with dentatotomy</article-title><source>Confin neurol</source><volume>34</volume><fpage>320</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">4566501</pub-id></citation></ref><ref id="b107-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neimat</surname><given-names>JS</given-names></name><name><surname>Patil</surname><given-names>PG</given-names></name><name><surname>Lozano</surname><given-names>AM</given-names></name></person-group><year>2006</year><article-title>Noval surgical therapies for Tourette syndrome</article-title><source>J Child Neurol</source><volume>21</volume><fpage>715</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16970873</pub-id></citation></ref><ref id="b108-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nordstrom</surname><given-names>EJ</given-names></name><name><surname>Burton</surname><given-names>FH</given-names></name></person-group><year>2002</year><article-title>A transgenic model of comorbid Tourette&#x02019;s syndrome and obsessive-compulsive disorder circuitry</article-title><source>Mol Psychiatry</source><volume>7</volume><fpage>617</fpage><lpage>25</lpage><fpage>524</fpage><pub-id pub-id-type="pmid">12140785</pub-id></citation></ref><ref id="b109-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nuttin</surname><given-names>B</given-names></name><name><surname>Gybels</surname><given-names>J</given-names></name></person-group><year>2003</year><article-title>Deep brain stimulation for psychiatric disorders</article-title><source>Neurosurg Clin N Am</source><volume>14</volume><fpage>xv</fpage><lpage>xvi</lpage><pub-id pub-id-type="pmid">12856486</pub-id></citation></ref><ref id="b110-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>MY</given-names></name><name><surname>Abosch</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><etal/></person-group><year>2002</year><article-title>Long-term hardware-related complications of deep brain stimulation</article-title><source>Neurosurgery</source><volume>50</volume><fpage>1268</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">12015845</pub-id></citation></ref><ref id="b111-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okun</surname><given-names>MS</given-names></name><name><surname>Fernandez</surname><given-names>HH</given-names></name><name><surname>Foote</surname><given-names>KD</given-names></name><etal/></person-group><year>2008</year><article-title>Avoiding deep brain stimulation failures in Tourette syndrome</article-title><source>J Neurol Neurosurg Psychiatry</source><volume>79</volume><fpage>111</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">18202200</pub-id></citation></ref><ref id="b112-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okun</surname><given-names>MS</given-names></name><name><surname>Tagliati</surname><given-names>M</given-names></name><name><surname>Pourfar</surname><given-names>M</given-names></name><etal/></person-group><year>2005</year><article-title>Management of referred deep brain stimulation failures</article-title><source>Arch Neurol</source><volume>62</volume><fpage>1250</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15956104</pub-id></citation></ref><ref id="b113-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pehek</surname><given-names>EA</given-names></name><name><surname>Nocjar</surname><given-names>C</given-names></name><name><surname>Roth</surname><given-names>BL</given-names></name><etal/></person-group><year>2006</year><article-title>Evidence for preferential involvement of 5-HT2A serotonin receptors in stress-and drug-induced dopamine release in the rat medial prefrontal cortex</article-title><source>Neuropsychopharmacology</source><volume>31</volume><fpage>265</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">15999145</pub-id></citation></ref><ref id="b114-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>B</given-names></name><name><surname>Riddle</surname><given-names>MA</given-names></name><name><surname>Cohen</surname><given-names>DJ</given-names></name><etal/></person-group><year>1993</year><article-title>Reduced basal ganglia volumes in Tourette&#x02019;s syndrome using three-dimensional reconstruction techniques from magnetic resonance images</article-title><source>Neurology</source><volume>43</volume><fpage>941</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8492950</pub-id></citation></ref><ref id="b115-ndt-4-1111"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>BS</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Cohen</surname><given-names>DJ</given-names></name><name><surname>Jankovic</surname><given-names>J</given-names></name><name><surname>Goetz</surname><given-names>CG</given-names></name></person-group><year>2001</year><article-title>Neuroimaging studies of Tourette syndrome: a decade of progress</article-title><source>Tourette syndrome. Volume 85 of Advances in neurology</source><publisher-loc>Philadelphia</publisher-loc><publisher-name>Lippincott Williams and Wilkins</publisher-name><fpage>179</fpage><lpage>96</lpage></citation></ref><ref id="b116-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>M</given-names></name><name><surname>Doran</surname><given-names>M</given-names></name><name><surname>Trimble</surname><given-names>M</given-names></name><etal/></person-group><year>1990</year><article-title>The treatment of Gilles de la Tourette syndrome by limbic leucotomy</article-title><source>J Neurol Neurosurg Psychiatry</source><volume>53</volume><fpage>691</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">2213047</pub-id></citation></ref><ref id="b117-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>MM</given-names></name><name><surname>Stern</surname><given-names>JS</given-names></name></person-group><year>2000</year><article-title>Gilles de la Tourette syndrome: symptomatic treatment based on evidence</article-title><source>Eur Child Adolesc Psychiatry</source><volume>9</volume><fpage>I/60</fpage><lpage>I/75</lpage></citation></ref><ref id="b118-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>MM</given-names></name><name><surname>Trimble</surname><given-names>MR</given-names></name><name><surname>Lees</surname><given-names>AJ</given-names></name></person-group><year>1989</year><article-title>Self-injurious behaviour and the Gilles de la Tourette syndrome: a clinical study and review of the literature</article-title><source>Psychol Med</source><volume>19</volume><fpage>611</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">2678199</pub-id></citation></ref><ref id="b119-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>MM</given-names></name></person-group><year>2000</year><article-title>Tourette syndrome, associated conditions and the complexities of treatment</article-title><source>Brain</source><volume>123</volume><fpage>425</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">10686169</pub-id></citation></ref><ref id="b120-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sachdev</surname><given-names>P</given-names></name><name><surname>Sachdev</surname><given-names>J</given-names></name></person-group><year>1997</year><article-title>Sixty years of psychosurgery: its present status and its future</article-title><source>J Aust N Z J Psychiatry</source><volume>31</volume><fpage>457</fpage><lpage>64</lpage></citation></ref><ref id="b121-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakas</surname><given-names>DE</given-names></name><name><surname>Kouyialis</surname><given-names>AT</given-names></name><name><surname>Boviatsis</surname><given-names>EJ</given-names></name><etal/></person-group><year>2007</year><article-title>Technical aspects and considerations of deep brain stimulation surgery for movement disorders</article-title><source>Acta Neurochir Suppl</source><volume>97</volume><fpage>163</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">17691301</pub-id></citation></ref><ref id="b122-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sansur</surname><given-names>CA</given-names></name><name><surname>Frysinger</surname><given-names>RC</given-names></name><name><surname>Pouratian</surname><given-names>N</given-names></name><etal/></person-group><year>2007</year><article-title>Incidence of symptomatic hemorrhage after stereotactic electrode placement</article-title><source>J Neurosurg</source><volume>107</volume><fpage>998</fpage><lpage>1003</lpage><pub-id pub-id-type="pmid">17977273</pub-id></citation></ref><ref id="b123-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sawle</surname><given-names>GV</given-names></name><name><surname>Lees</surname><given-names>AJ</given-names></name><name><surname>Hymas</surname><given-names>NF</given-names></name><etal/></person-group><year>1993</year><article-title>The metabolic effects of limbic leucotomy in Gilles de la Tourette syndrome</article-title><source>J Neurol Neurosurg Psychiatry</source><volume>56</volume><fpage>1016</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8410025</pub-id></citation></ref><ref id="b124-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serra-Mestres</surname><given-names>J</given-names></name><name><surname>Ring</surname><given-names>HA</given-names></name><name><surname>Costa</surname><given-names>DA</given-names></name><etal/></person-group><year>2004</year><article-title>Dopamine transporter binding in Gilles de la Tourette syndrome: A [123I]FP-CIT/SPECT study</article-title><source>Acta Psychiatr Scand</source><volume>109</volume><fpage>140</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">14725596</pub-id></citation></ref><ref id="b125-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sershen</surname><given-names>H</given-names></name><name><surname>Hashim</surname><given-names>A</given-names></name><name><surname>Lajtha</surname><given-names>A</given-names></name></person-group><year>2000</year><article-title>Serotonin-mediated striatal dopamine release involves the dopamine uptake site and the serotonin receptor</article-title><source>Brain Res Bull</source><volume>53</volume><fpage>353</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11113592</pub-id></citation></ref><ref id="b126-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Servello</surname><given-names>D</given-names></name><name><surname>Porta</surname><given-names>M</given-names></name><name><surname>Sassi</surname><given-names>M</given-names></name><etal/></person-group><year>2008</year><article-title>Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation</article-title><source>J Neurol Neurosurg Psychiatry</source><volume>79</volume><fpage>136</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">17846115</pub-id></citation></ref><ref id="b127-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shahed</surname><given-names>J</given-names></name><name><surname>Poysky</surname><given-names>J</given-names></name><name><surname>Kenney</surname><given-names>C</given-names></name><etal/></person-group><year>2007</year><article-title>GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbidities</article-title><source>Neurology</source><volume>68</volume><fpage>159</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">17210901</pub-id></citation></ref><ref id="b128-ndt-4-1111"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>AK</given-names></name><name><surname>Shapiro</surname><given-names>ES</given-names></name><name><surname>Young</surname><given-names>JG</given-names></name><etal/></person-group><person-group person-group-type="editor"><name><surname>Shapiro</surname><given-names>AK</given-names></name><name><surname>Shapiro</surname><given-names>ES</given-names></name><name><surname>Young</surname><given-names>JG</given-names></name><etal/></person-group><year>1988</year><article-title>Signs, symptoms, and clinical course</article-title><source>Gilles de la Tourette Syndrome</source><edition>2nd ed</edition><publisher-loc>New York</publisher-loc><publisher-name>Raven Press</publisher-name><fpage>127</fpage><lpage>93</lpage></citation></ref><ref id="b129-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sillay</surname><given-names>KA</given-names></name><name><surname>Larson</surname><given-names>PS</given-names></name><name><surname>Starr</surname><given-names>PA</given-names></name></person-group><year>2008</year><article-title>Deep brain stimulator hardware-related infections: incidence and management in a large series</article-title><source>Neurosurgery</source><volume>62</volume><fpage>360</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">18382313</pub-id></citation></ref><ref id="b130-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>HS</given-names></name><name><surname>Butler</surname><given-names>IJ</given-names></name><name><surname>Tune</surname><given-names>LE</given-names></name><etal/></person-group><year>1982</year><article-title>Dopaminergic dysfunction in Tourette syndrome</article-title><source>Ann Neurol</source><volume>12</volume><fpage>361</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">6184010</pub-id></citation></ref><ref id="b131-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>HS</given-names></name><name><surname>Reiss</surname><given-names>AL</given-names></name><name><surname>Brown</surname><given-names>JE</given-names></name><etal/></person-group><year>1993</year><article-title>Volumetric MRI changes in basal ganglia of children with Tourette syndrome</article-title><source>Neurology</source><volume>43</volume><fpage>950</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8492951</pub-id></citation></ref><ref id="b132-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>HS</given-names></name><name><surname>Szymanski</surname><given-names>S</given-names></name><name><surname>Giuliano</surname><given-names>J</given-names></name><etal/></person-group><year>2002</year><article-title>Elevated intrasynaptic dopamine release in Tourette&#x02019;s syndrome measured by PET</article-title><source>Am J Psychiatry</source><volume>159</volume><fpage>1329</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">12153825</pub-id></citation></ref><ref id="b133-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>HS</given-names></name></person-group><year>2001</year><article-title>The treatment of tics</article-title><source>Curr Neurol Neurosci Rep</source><volume>1</volume><fpage>195</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">11898516</pub-id></citation></ref><ref id="b134-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Snyder</surname><given-names>SH</given-names></name><name><surname>Taylor</surname><given-names>KM</given-names></name><name><surname>Coyle</surname><given-names>JT</given-names></name><etal/></person-group><year>1970</year><article-title>The role of brain dopamine in behavioural regulation and the actions of psychotropic drugs</article-title><source>Am J Psychiatry</source><volume>127</volume><fpage>199</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">4319649</pub-id></citation></ref><ref id="b135-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>E</given-names></name><name><surname>Silbersweig</surname><given-names>DA</given-names></name><name><surname>Chee</surname><given-names>K-Y</given-names></name><etal/></person-group><year>2000</year><article-title>A functional neuroanatomy of tics in tourette syndrome</article-title><source>Arch Gen Psychiatry</source><volume>57</volume><fpage>741</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10920461</pub-id></citation></ref><ref id="b136-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>H</given-names></name></person-group><year>1964</year><article-title>The syndrome of Gilles de la Tourette and its treatment</article-title><source>Med Ann Dist Columbia</source><volume>33</volume><fpage>277</fpage><lpage>9</lpage><fpage>304</fpage><pub-id pub-id-type="pmid">14155608</pub-id></citation></ref><ref id="b137-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stoetter</surname><given-names>B</given-names></name><name><surname>Braun</surname><given-names>AR</given-names></name><name><surname>Randolph</surname><given-names>C</given-names></name><etal/></person-group><year>1992</year><article-title>Functional neuroanatomy of Tourette syndrome. Limbic-motor interactions studied with FDG PET</article-title><source>Adv Neurol</source><volume>58</volume><fpage>213</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">1414626</pub-id></citation></ref><ref id="b138-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Krahl</surname><given-names>SE</given-names></name><name><surname>Zhan</surname><given-names>S</given-names></name><etal/></person-group><year>2005</year><article-title>Improved capsulotomy for refractory Tourette&#x02019;s syndrome</article-title><source>Stereotact Func Neurosurg</source><volume>83</volume><fpage>55</fpage><lpage>6</lpage></citation></ref><ref id="b139-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>NR</given-names></name><name><surname>Geyer</surname><given-names>MA</given-names></name><name><surname>Braff</surname><given-names>DL</given-names></name></person-group><year>2001</year><article-title>Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges</article-title><source>Psychopharmacology</source><volume>156</volume><fpage>194</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">11549223</pub-id></citation></ref><ref id="b140-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>NR</given-names></name><name><surname>Sutherland</surname><given-names>AN</given-names></name></person-group><year>2005</year><article-title>Using animal models to develop therapeutics for Tourette Syndrome</article-title><source>Pharmacol Ther</source><volume>108</volume><fpage>281</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">15970330</pub-id></citation></ref><ref id="b141-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>NR</given-names></name><name><surname>Sutherland</surname><given-names>AN</given-names></name></person-group><year>2006</year><article-title>Preclinical models relevant to Tourette syndrome</article-title><source>Adv Neurol</source><volume>99</volume><fpage>69</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">16536353</pub-id></citation></ref><ref id="b142-ndt-4-1111"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>NR</given-names></name><name><surname>Young</surname><given-names>AB</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Cohen</surname><given-names>DJ</given-names></name><name><surname>Jankovic</surname><given-names>J</given-names></name><name><surname>Goetz</surname><given-names>CG</given-names></name></person-group><year>2001</year><article-title>Neuropathology in Tourette syndrome: an update</article-title><source>Tourette syndrome, Volume 85 of Advances in neurology</source><publisher-loc>Philadelphia</publisher-loc><publisher-name>Lippincott Williams and Wilkins</publisher-name><fpage>179</fpage><lpage>96</lpage></citation></ref><ref id="b143-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Temel</surname><given-names>Y</given-names></name><name><surname>Ackermans</surname><given-names>L</given-names></name><name><surname>Celik</surname><given-names>H</given-names></name><etal/></person-group><year>2004</year><article-title>Management of hardware infections following deep brain stimulation</article-title><source>Acta Neurochir (Wien)</source><volume>146</volume><fpage>355</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">15057529</pub-id></citation></ref><ref id="b144-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Temel</surname><given-names>Y</given-names></name><name><surname>Visser-Vandewalle</surname><given-names>V</given-names></name></person-group><year>2004</year><article-title>Surgery in Tourette syndrome</article-title><source>Mov Disord</source><volume>19</volume><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">14743354</pub-id></citation></ref><ref id="b145-ndt-4-1111"><citation citation-type="journal"><collab>The Tourette Syndrome Classification Study Group</collab><year>1993</year><article-title>Definitions and classifications of tic disorders</article-title><source>Arch Neurol</source><volume>50</volume><fpage>1013</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8215958</pub-id></citation></ref><ref id="b146-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van der Linden</surname><given-names>C</given-names></name><name><surname>Colle</surname><given-names>H</given-names></name><name><surname>Vandewalle</surname><given-names>V</given-names></name><etal/></person-group><year>2002</year><article-title>Successful treatment of tics with bilateral internal pallidum (GPi) stimulation in a 27-year-old male patient with Gille de la Tourette&#x02019;s syndrome (GTS)</article-title><source>Mov Disord</source><volume>17</volume><issue>Suppl 5</issue><fpage>S341</fpage></citation></ref><ref id="b147-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Visser-Vandewalle</surname><given-names>V</given-names></name><name><surname>Ackermans</surname><given-names>L</given-names></name><name><surname>van der Linden</surname><given-names>C</given-names></name><etal/></person-group><year>2006</year><article-title>Deep brain stimulation in Gilles de la Tourette&#x02019;s syndrome</article-title><source>Neurosurgery</source><volume>58</volume><fpage>E590</fpage><pub-id pub-id-type="pmid">16528175</pub-id></citation></ref><ref id="b148-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Visser-Vandewalle</surname><given-names>V</given-names></name><name><surname>Temel</surname><given-names>Y</given-names></name><name><surname>Boon</surname><given-names>P</given-names></name><etal/></person-group><year>2003</year><article-title>Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome</article-title><source>J Neurosurg</source><volume>99</volume><fpage>1094</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">14705742</pub-id></citation></ref><ref id="b149-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Visser-Vandewalle</surname><given-names>V</given-names></name><name><surname>van der Linden</surname><given-names>C</given-names></name><name><surname>Groenewegen</surname><given-names>HJ</given-names></name><etal/></person-group><year>1999</year><article-title>Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus</article-title><source>Lancet</source><volume>353</volume><fpage>724</fpage></citation></ref><ref id="b150-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Visser-Vandewalle</surname><given-names>V</given-names></name></person-group><year>2007</year><article-title>DBS in Tourette syndrome: rationale, current status and future prospects</article-title><source>Acta Neurochir Suppl</source><volume>97</volume><fpage>215</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">17691307</pub-id></citation></ref><ref id="b151-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whitty</surname><given-names>CWM</given-names></name><name><surname>Duffield</surname><given-names>JE</given-names></name><name><surname>Tow</surname><given-names>PM</given-names></name><etal/></person-group><year>1952</year><article-title>Anterior cingulectomy in the treatment of mental disease</article-title><source>Lancet</source><volume>1</volume><fpage>475</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">14898782</pub-id></citation></ref><ref id="b152-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>SS</given-names></name><name><surname>Jones</surname><given-names>DW</given-names></name><name><surname>Knable</surname><given-names>MB</given-names></name><etal/></person-group><year>1996</year><article-title>Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding</article-title><source>Science</source><volume>273</volume><fpage>1225</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8703056</pub-id></citation></ref><ref id="b153-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>DF</given-names></name><name><surname>Pearlson</surname><given-names>GD</given-names></name><name><surname>Young</surname><given-names>LT</given-names></name><etal/></person-group><year>1989</year><article-title>D2 dopamine receptors are elevated in neuropsychiatric disorders other than schizophrenia</article-title><source>J Cereb Blood Flow Metab</source><volume>9</volume><issue>Suppl 1</issue><fpage>S593</fpage></citation></ref><ref id="b154-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>DF</given-names></name><name><surname>Singer</surname><given-names>HS</given-names></name><name><surname>Brandt</surname><given-names>J</given-names></name><etal/></person-group><year>1997</year><article-title>D2-like dopamine receptor density in Tourette syndrome measured by PET</article-title><source>J Nucl Med</source><volume>38</volume><fpage>1243</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9255158</pub-id></citation></ref><ref id="b155-ndt-4-1111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zimmerman</surname><given-names>AM</given-names></name><name><surname>Abrams</surname><given-names>MT</given-names></name><name><surname>Giuliano</surname><given-names>JD</given-names></name><etal/></person-group><year>2000</year><article-title>Subcortical volumes in girls with Tourette syndrome</article-title><source>Neurology</source><volume>54</volume><fpage>2224</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10881244</pub-id></citation></ref></ref-list></back><floats-wrap><fig id="f1-ndt-4-1111" position="float"><label>Figure 1</label><caption><p>Schematic representation of basal ganglia circuitry (modified from Visser-Vandewalle et al 1997), with excitatory (glutamatergic) projections <inline-graphic xlink:href="ndt-4-1111f3.jpg"/> and inhibitory (GAB-Aergic) projections &#x02192;. Normally, dopamine, acting via D1 dopamine receptors, has an excitatory influence on striatal projections to the GPi and, acting via D2 dopamine receptors, an inhibitory influence on striatal projections to the GPe, maintaining a balance between the activities of the direct and indirect basal ganglia pathways. According to the dopaminergic hypothesis of TS pathophysiology, dopaminergic hyperactivity causes increased activity in the direct pathway (indicated by the heavier weighted lines) and decreased activity in the indirect pathway, which serves to enhance thalamocortical activity. In TS, the thalamus, caudate-putamen, and GPe become pathologically hyperactive, and the GPi and STN become pathologically hypoactive.</p><p><bold>Abbreviations:</bold> GPi, globus pallidus pars internus; GPe, globus pallidus pars externus; STN, subthalamic nucleus; DA, dopamine.</p></caption><graphic xlink:href="ndt-4-1111f1"/></fig><fig id="f2-ndt-4-1111" position="float"><label>Figure 2</label><caption><p>Sagittal magnetic resonance image demonstrating the sites of lesions for TS.</p><p><bold>Notes:</bold> 1, frontal leucotomy; 2, cingulotomy; 3, zona incerta lesion; 4, thalamotomy; 5, hypothalamotomy; and 6, dentatotomy.</p></caption><graphic xlink:href="ndt-4-1111f2"/></fig><table-wrap id="t1-ndt-4-1111" position="float"><label>Table 1</label><caption><p>Clinical studies of neurosurgical lesions for Tourette&#x02019;s syndrome</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Study effects</th><th align="left" rowspan="1" colspan="1">Study design</th><th align="left" rowspan="1" colspan="1">n</th><th align="left" rowspan="1" colspan="1">Comorbid diagnoses</th><th align="left" rowspan="1" colspan="1">Lesion</th><th align="left" rowspan="1" colspan="1">Outcomes</th><th align="left" rowspan="1" colspan="1">Adverse</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b12-ndt-4-1111">Baker 1962</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">anxiety</td><td align="left" rowspan="1" colspan="1">Bimedial frontal leucuotomy</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 1 year</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>frontal lobe abscess</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>tics and panic attacks &#x0201c;markedly reduced&#x0201d;</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b136-ndt-4-1111">Stevens 1964</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">Transorbital lobotomy</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 9 years</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>obesity</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>significant decrease in frequency, duration, and amplitude of tics</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b70-ndt-4-1111">Hassler and Dieckmann 1970</xref></td><td align="left" rowspan="1" colspan="1">Case series</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">OCD</td><td align="left" rowspan="1" colspan="1">Thalamotomy (bilaterally; targeted rostral intralaminar and medial nuclei)</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: time not specified</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>mood alterations</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: techniques not specified</p></list-item><list-item><p>70%&#x02013;100% improvement of coprolalia and tics</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b106-ndt-4-1111">N&#x000e1;dvorn&#x000ed;k et al 1972</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">not indicated</td><td align="left" rowspan="1" colspan="1">Dentatotomy (bilateral)</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: time not specified</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>none reported</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>decrease in motor tics and resolution of vocal tics</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b38-ndt-4-1111">de Divitiis et al 1977</xref></td><td align="left" rowspan="1" colspan="1">Case series</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">OCD</td><td align="left" rowspan="1" colspan="1">Thalamotomy (unilateral, except for 1 patient who also received a contralateral thalamotomy)</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: at least 1 year (exact time not specified)</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>&#x0201c;prolonged mental confusion&#x0201d; (1 patient)</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>complete remission of tics for &#x0003e;1 year but then recurrence of symptoms 2 patients)</p></list-item><list-item><p>no improvement of tics (1 patient)</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b84-ndt-4-1111">Kurlan et al 1988</xref></td><td align="left" rowspan="1" colspan="1">Case series</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">OCD</td><td align="left" rowspan="1" colspan="1">Cingulotomy</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: time not specified</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>none reported</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>transient improvement of tics</p></list-item><list-item><p>slight improvement of ritualistic behavior</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b85-ndt-4-1111">Kurlan et al 1990</xref></td><td align="left" rowspan="1" colspan="1">Case series</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">OCD</td><td align="left" rowspan="1" colspan="1">Cingulotomy (bilateral anterior; 1 patient had procedure repeated 8 months after first)</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: up to 2 years</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>aseptic meningitis for patient who underwent two procedures</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: clinical rating scales not utilized</p></list-item><list-item><p>No effects on tics or coprolalia</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b116-ndt-4-1111">Robertson et al 1990</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">SIB</td><td align="left" rowspan="1" colspan="1">Cingulotomy (bilateral)</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 2 years</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>mild apathy</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1">intellectual impairment</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: LOI, BDI</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>general intellectual impairment</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1">difficulties with organization concentration</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>75% &#x02193; severity of tics</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b87-ndt-4-1111">Leckman et al 1993</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">OCD</td><td align="left" rowspan="1" colspan="1">Cingulotomy (bilateral anterior) and infrathalamic lesion (bilateral)</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 16 months</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>sepsis</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Left cingulated and infrathalamic lesions repeated 1 month later</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: YBOCS, YGTSS</p></list-item><list-item><p>improvement in tics (YGTSS score &#x02193; from 22 to 15)</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>dysarthria, dysphagia, dysphonia</p></list-item><list-item><p>severe handwriting problems, micrographia</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b123-ndt-4-1111">Sawle et al 1993</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">OCD, SIB</td><td align="left" rowspan="1" colspan="1">Hypothalamus (anterior) and cingulotomy (inferior)</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 21 months</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>none reported</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>by 19 months no clinical signs of Tourette&#x02019;s syndrome</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b11-ndt-4-1111">Baer et al 1994</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">OCD</td><td align="left" rowspan="1" colspan="1">Cingulotomy (second cingulotomy performed 18 months after the first)</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 18 months (first cingulotomy); 13 months (second cingulotomy)</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>none reported</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: YBOCS, BDI, CGI scale</p></list-item><list-item><p>by 18 months following 1st surgery, depression and anxiety improved, but OCD and tics not improved</p></list-item><list-item><p>by 13 months following 2nd surgery, OCD, depression, and anxiety improved, but tics worse</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b82-ndt-4-1111">Kulisevsky et al 1995</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">OCD</td><td align="left" rowspan="1" colspan="1">Leucotomy (bilateral prefrontal)</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 39 years</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>bulimia, weight gain, compulsive smoking appeared 4 years after surgery and deemed to be surgical</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: YBOCS, LOI, HDRS TBSA, TSGS</p></list-item><list-item><p>Disappearance of coprolalia, copropraxia, and OCD 5 years after surgery that recurred 38 years later</p></list-item></list></td><td align="left" rowspan="1" colspan="1">surgical side effects</td></tr><tr><td align="left" rowspan="1" colspan="1">Korzenev et al 1997</td><td align="left" rowspan="1" colspan="1">Case series</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">OCD</td><td align="left" rowspan="1" colspan="1">Details regarding the lesion targets, follow-up period, evaluation techniques and effects on tics not specified</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b10-ndt-4-1111">Babel et al 2001</xref></td><td align="left" rowspan="1" colspan="1">Case series</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">ADHD (3 patients)</td><td align="left" rowspan="1" colspan="1">ZI, LM, VL</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 7 years (range 3.5&#x02013;17 years) (11 patients); 5 patients lost to follow-up</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Cerebellar signs, dystonia, and dysarthria (11 patients)</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">9 patients &#x02013; bilateral lesions</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: Tic severity rating scale</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>transient postoperative morbidity (6 patients)</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">ZI targeted in 15 patients</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>significant improvement of both vocal and motor tic scores (33%&#x02013;75% and 25%&#x02013;80% in tic severity reduction, respectively)</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>hemiparesis (3 patients)</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">ZI and VL/LM in 11 patients</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>disabling hemiballism (1 patient)</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b6-ndt-4-1111">Anandan et al 2004</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">SIB, OCD, ADHD</td><td align="left" rowspan="1" colspan="1">Cingulotomy (targeted area above corpus callosum) and urinating then limbic leucotomy (7 months afterwards, targeted area under caudate nucleus proximal to previous lesion site)</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up (cingulotomy): 6 months</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Cingulotomy: headaches, difficulty</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>initial period of improvement of SIB but then recurrence of tics and SIB</p></list-item><list-item><p>Follow-up (leucotomy): not specified</p></list-item><list-item><p>&#x02193; frequency and severity of SIB</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Leucotomy headaches, drowsiness</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b138-ndt-4-1111">Sun et al 2005</xref></td><td align="left" rowspan="1" colspan="1">Case series</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">OCD SIB (4 patients)</td><td align="left" rowspan="1" colspan="1">Capsulotomy [targeted the anterior 1/3 (7 patients) or posterior 1/3 (5 patients) of anterior internal capsule], bilaterally</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 3&#x02013;18 months (mean 13.4)</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>no severe, permanent side effects</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Reduction of tics immediately post-operatively after anterior internal capsule lesion; benefits decreased by 1 months post-operatively in 5 patients; only 2 patients demonstrated 80% &#x02193; in tics over sustained time period</p></list-item><list-item><p>4 patients with lesion of posterior internal capsule demonstrated significant and sustained reduction of tics; 1 patient had 50% &#x02193; of tics</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>transient urinary incontinence, memory complaints, confusion</p></list-item><list-item><p>delayed side effects: increased sexual behavior (3 patients), immature behavior (2 patients), akathisia (2 cases)</p></list-item></list></td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ndt-4-1111"><p><bold>Abbreviations:</bold> ADHD, attention deficit hyperactivity disorder; BDI, beck depression inventory; CGI, clinical global improvement scale; HDRS, hamilton depression rating scale; LM, lamella medialis thalamus; LOI, leyton obsessional inventory; OCD, obsessive-compulsive disorder; SIB, self-injurious behaviour; TBSA, tyrer brief scale for anxiety; TSGS, tourette&#x02019;s syndrome global scale; VL, ventrolateral nuclei of the thalamus; YBOCS, yale-brown obsessive compulsive scale; ZI, zona incerta.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-ndt-4-1111" position="float"><label>Table 2</label><caption><p>Clinical studies of deep brain stimulation for Tourette&#x02019;s syndrome</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Study</th><th align="left" rowspan="1" colspan="1">Study design</th><th align="left" rowspan="1" colspan="1">n</th><th align="left" rowspan="1" colspan="1">Comorbid diagnoses</th><th align="left" rowspan="1" colspan="1">DBS target(s)</th><th align="left" rowspan="1" colspan="1">Outcomes</th><th align="left" rowspan="1" colspan="1">Adverse effects</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b149-ndt-4-1111">Vandewalle et al 1999</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">Thalamus (rostral intralaminar and medial nuclei) bilaterally</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 1 year</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>none reported</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: videotape analysis of tics</p></list-item><list-item><p>complete abolishment of tics</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b146-ndt-4-1111">van der Linden et al 2002</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">depression</td><td align="left" rowspan="1" colspan="1">Thalamus (medial) and GPi bilaterally</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 6 months</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>none reported</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: not specified</p></list-item><list-item><p>80% &#x02193; tics by thalamic DBS</p></list-item><list-item><p>95% &#x02193; tics by pallidal DBS</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b148-ndt-4-1111">Visser-Vandewalle et al 2003</xref></td><td align="left" rowspan="1" colspan="1">Case series</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">Thalamus (at level of the Voi, Cm, Spv) bilaterally</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 8 months &#x02013; 5 years</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>reduced energy at stimulus voltage required for optimal tic management</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: videotape analysis of tics</p></list-item><list-item><p>Resolution of all major tics</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>increased sexual drive (1 patient)</p></list-item><list-item><p>reduced sexual function (1 patient)</p></list-item><list-item><p>3 revisions of pulse and cables because of pain generator traction (2 patients)</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b50-ndt-4-1111">Flaherty et al 2005</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">AIC (ventral) bilaterally</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 18 months</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>mood alteration (high nucleus voltage stimulation at depression accumbens produced at and apathy, stimulation capsule in body of internal produced hypomania)</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: YGTSS</p></list-item><list-item><p>25% &#x02193; YGTSS in overall impairment</p></list-item><list-item><p>17% &#x02193; total tic score</p></list-item><list-item><p>20% &#x02193; global severity</p></list-item><list-item><p>45% &#x02193; tic severity and frequency and increased ability to suppress tics (according to patient)</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b42-ndt-4-1111">Diederich et al 2005</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">mild OCD</td><td align="left" rowspan="1" colspan="1">GPi bilaterally</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up:14 months</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>transient fatigue (several months)</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: YGTSS, BDI, STAI, SCL-90-R</p></list-item><list-item><p>73% &#x02193; tic frequency/minute</p></list-item><list-item><p>&#x02193; intensity of vocal tics</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>impaired rapidly alternating pronation and supination movements of left limbs</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b71-ndt-4-1111">Houeto et al 2005</xref></td><td align="left" rowspan="1" colspan="1">Prospective double blind</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Anxiety Depression SIB</td><td align="left" rowspan="1" colspan="1">Ce-Pf of thalamus, GPi, or both</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 2 years</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>weight loss</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: YGTSS, RVB- TRS, MADRS, BAS, BIS</p></list-item><list-item><p>Thalamic DBS: 64% &#x02193; YGTSS scores, 77% &#x02193; RVBTS scores</p></list-item><list-item><p>Pallidal DBS: 66% &#x02193; YGTSS scores, 54% &#x02193; RVBTS scores</p></list-item><list-item><p>combined DBS: 60% &#x02193; YGTSS scores, 77% &#x02193; RVBTS scores</p></list-item><list-item><p>elimination of SIB</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b2-ndt-4-1111">Ackermans et al 2006</xref></td><td align="left" rowspan="1" colspan="1">Case series</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">OCD</td><td align="left" rowspan="1" colspan="1">Patient 1: Thalamus (at level of Voi, Cm, and Spv) bilaterally</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 1 year</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>feeling of &#x02193; energy at required stimulus voltage reduction for optimal tic</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: Videotaping and counting tics</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>&#x02193; sexual functions</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Patient 2: Thalamus (at level of Voi, Cm, and Spv) and GPi (postero ventrolateral) bilaterally</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>&#x02193; tics [from 20 to 3/minute (patient 1) and 28 to 2/minute (patient 2)]</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>dystonic jerk when stimulator activated</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Complete resolution of all major tics and compulsions</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b55-ndt-4-1111">Gallagher et al 2006</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">GPi bilaterally</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: &#x0201c;months&#x0201d; (time not specified)</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Infection of stimulator lead</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>evaluation of tics not discussed</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b1-ndt-4-1111">Ackermans et al 2007</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">SIB</td><td align="left" rowspan="1" colspan="1">Thalamus (medial part at crosspoint of Cm, Voi, hemorrhage and Spv) bilaterally</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>effects on tics not discussed</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>vertical gaze palsy due to intracerebral</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b81-ndt-4-1111">Kuhn et al 2007</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">OCD</td><td align="left" rowspan="1" colspan="1">nucleus accumbens and anterior limb of the internal capsule</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 2.5 years</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>none reported</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation:YGTSS, MRVRS, GAF, YBOCS</p></list-item><list-item><p>41%, 50%, and 52% remission rates in YGTSS, MRVRS, and YBOCS, respectively</p></list-item><list-item><p>considerable improvement in psycho-social functioning (GAF &#x02191;from 7 to 41)</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b96-ndt-4-1111">Maciunas et al 2007</xref></td><td align="left" rowspan="1" colspan="1">Prospective, randomized, double-blind, crossover</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">ADHD (3 patients) OCD (4 patients) depression (5 patients)</td><td align="left" rowspan="1" colspan="1">Thalamus (Cm, Voi, and Spv) bilaterally</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 3 months</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>none related to the procedures</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: YGTSS, SF-36, VAS, BDI-2, HAM-D, HAM-A, YBOCS TSSL, MRVRS</p></list-item><list-item><p>Significant &#x02193; in MRVRS (primary outcome measure) in bilateral on state</p></list-item><list-item><p>Significant improvement in tic counts and YGTSS and TSLS scores (secondary outcome measures)</p></list-item><list-item><p>Quality of life indices improved (SF-36 and VAS scores)</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b127-ndt-4-1111">Shahed et al 2007</xref></td><td align="left" rowspan="1" colspan="1">Case report</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">OCD, ADHD, Depression, anxiety</td><td align="left" rowspan="1" colspan="1">GPi bilaterally</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 6 months</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>none reported</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: YGTSS, TSSR, MRVRS YBOCS, SF-36 v2, BRIEF</p></list-item><list-item><p>84% &#x02193; total YGTSS scores</p></list-item><list-item><p>88% &#x02193; TSSR scores</p></list-item><list-item><p>21% &#x02193; MRVRS scores</p></list-item><list-item><p>65% &#x02191; SF-36 v2 scores</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="b128-ndt-4-1111">Servello et al 2008</xref></td><td align="left" rowspan="1" colspan="1">Case series</td><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">OCD (9 patients) SIB (9 patients) Depression (3 patients) ADHD (1 patient)</td><td align="left" rowspan="1" colspan="1">Thalamus (Ce-Pf andVoi) bilaterally</td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Follow-up: 3&#x02013;18 months</p></list-item></list></td><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>none reported</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Evaluation: YGTSS</p></list-item><list-item><p>65% &#x02193; in YGTSS scores</p></list-item><list-item><p>17 patients demonstrated significant improvement of tic severity</p></list-item><list-item><p>3 patients required no further medical Therapy</p></list-item></list></td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn2-ndt-4-1111"><p><bold>Abbreviations:</bold> ADHD, attention deficit hyperactivity disorder; AIC, anterior internal capsule; BAS, brief anxiety scale; BDI, beck depression inventory; BIS, baratt&#x02019;s impulsivity scale; BRIEF, behaviour rating inventory of executive function; Ce-Pf, centromedian-parafascicular complex of the thalamus; Cm, centromedian nucleus; GAF, global assessment of functioning scale; GPi, globus pallidus pars internus; HAM-A, hamilton rating scale for anxiety; HAM-D, hamilton rating scale for depression; MADRS, montgomery-asberg depression rating scale; MRVRS, modified rush video rating scale; OCD, obsessive-compulsive disorder; RVBTS, rush video-based tic rating scale; Spv, substantia periventricularis; SCL-90-R, symptom checklist-90-R; SF-36, short form 36; SIB, self-injurious behaviour; STAI, state-trait anxiety Inventory; TSSL, tourette syndrome symptom list; TSSR, tic symptom self-report; v2, version 2; VAS, visual analog scale; Voi, nucleus ventro-oralis internus; YBOCS, yale-brown obsessive-compulsive scale; YGTSS, yale global tic severity scale.</p></fn></table-wrap-foot></table-wrap></floats-wrap></article>